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Summary
Toll like receptors (TLR) have emerged as key upstream mediators of inflammation at 
many tissue sites in humans. Parturition is considered an inflammatory process so it was 
hypothesised that TLR activity within gestation-associated tissues, such as the placenta, 
might have an important role in the initiation and/or maintenance of normal term labour 
and in various pathological states of pregnancy such as infection associated preterm 
labour.
Expression of transcripts for TLR1-10 was confirmed in term (>37 weeks of gestation) 
human placentas collected in the absence of labour (elective caesarean sections, term 
non-laboured) and after the completion of labour at term (normal vaginal delivery, term 
laboured,) and preterm ( <37 weeks gestation, preterm delivery). Explants of placental 
tissue were cultured in vitro in the presence of ligands for TLR 1-9 (an agonist of 
TLR 10 has not yet been identified). Cytokine (TNFa, IL-6, IL-8 & IL-10) production 
into the culture supernatants was then measured using ELISA.
Reactivity to all agonists except CpG oligonucleotides was observed in all the three 
groups studied indicating that, other than TLR9, all of the receptors studied yielded 
functional responses. Placentas collected after the completion of labour (term laboured; 
n=17) had significantly more LPS (TLR4 agonist) and R848 (TLR7/8) agonist induced 
TNFa than those obtained in the absence of labour (term non-laboured", n=17). In 
contrast, gene expression analysis revealed that transcripts for TLR2 and TLR5 only 
were significantly elevated in association with labour. These findings indicate that there 
is no relationship between changes in mRNA expression and function of these receptors 
within the placenta.
The study of placentas collected following preterm spontaneous vaginal delivery 
(preterm svd\ n=10) compared with those obtained after term laboured (n=17) revealed 
that significantly less TNFa and IL-6 were produced by placentas following preterm 
delivery in response to all TLR agonists. In contrast, the expression of TLR transcripts 
was found not to be statistically different for any of the TLRsl-10 in these two groups.
Thus the human term placenta expresses a variety of functional TLRs and whilst LPS 
and R848 mediated TNFa increase at term labour, more detailed analysis of contributing 
cell types and signalling molecules is required to elucidate the role of this family of 
receptors in parturition.
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CHAPTER 1 
INTRODUCTION
1.1 PRETERM LABOUR
Preterm birth, defined as delivery before 37 weeks of pregnancy (WHO 1993) has an 
estimated worldwide incidence of 13 million per annum. It complicated about 11.9% of 
all pregnancies in 2001 (Martin, Hamilton et al. 2002). The number of babies bom 
preterm has been increasing steadily for the past two decades reaching up to 25% in 
some developed and developing countries (Steer 2005). Prematurity alone accounts for 
75% of perinatal morbidity and mortality in the developed world (Besinger 1993). Of 
the 600,000 live births in the UK every year, about 8,000 will be very premature and 
weigh less than 1500 grams: of these around 1,600 die, 600 develop cerebral palsy, and 
many others will have a variety of disabilities such as bronchopulmonary dysplasia, 
intra-ventricular haemorrhage, patent ductus arteriosus, retinopathy of prematurity and 
poor school performance in later years (Hole and Tressler 2001). Thus attempts to 
reduce the present wastage of foetal life are essential.
The second and third trimesters of pregnancy are vital for maturation of the fetal lungs 
and other organs in preparation for extrauterine life. Interruption of this development by 
very early delivery markedly diminishes the chances of survival of the newborn even 
with the best neonatal care. Preterm birth thus also imposes a significant economic 
burden, from both immediate neonatal intensive care unit costs (estimated at 
approximately 10% of all paediatric health care costs in the United States and amounting 
to approximately $5.5-6 billion/year) together with the long-term costs for the 
residential care or support of infants with residual disabilities (Lewitt, Baker et al. 1995).
If the problem of prematurity is to be tackled successfully, there are three facets to 
consider -  firstly, and ideally, the prevention of preterm labour, or failing that successful 
recognition and implementation of treatment directed at inhibiting myometrial 
contractions, and lastly the care of the preterm newborn. Any or all of these would 
considerably affect perinatal morbidity and mortality statistics and therefore deserve to 
be the number one priority of contemporary obstetrics.
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Despite much effort during the past 40 years, nearly all of the improvements with 
treating this pregnancy complication are due to advances in neonatology (Lumley 2003). 
Indeed, the probability of infant survival for 30 completed weeks of gestation is now 
90% compared to only 45% in 1960 (Reichman 2005) and the limit of fetal survival has 
been extended to 24 weeks (Creasy and lams 1999). The 2% of babies bom before 32 
weeks, however, account for about 70% of all infant mortality (Lopez-Bemal and 
Tamby 2000; Martin, Hamilton et al. 2002).
Whilst delaying delivery by using tocolysis would decrease the rate of long-term 
morbidity there is as yet no effective treatment available for this. Alternatively, accurate 
prediction of preterm birth would at least allow the administration of corticosteroids 
known to significantly reduce the associated mortality and morbidity. However, there is 
currently no accurate method of predicting preterm birth and, moreover, half of all 
preterm births occur in women with no known clinical risk factors (lams, Goldenberg et 
al. 2001).
Thus, the prevention of preterm labour seems to be the most viable step in dealing with 
the problem of prematurity. Certainly this requires a better understanding of the basic 
aetiology of preterm labour. However the onset and progress of labour, both at term and 
preterm are only beginning to be understood (Farina and Winkelman 2005).
L 1.1 Aetiology of Preterm labour
In his report on ‘Epidemiology of preterm birth’, Main (Main 1988) classified factors 
inherent in causation of preterm birth into proximate causes and risk factors.
Proximate causes were categorised into four definite obstetric diagnoses directly 
responsible for preterm delivery namely, 1) idiopathic preterm labour, 2) preterm 
premature rupture of membranes (PPROM), 3) maternal medical and obstetrical 
complications, 4) fetal distress or demise.
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Romero (Romero and Mazor 1988) later reported the individual contribution of these 
categories to be approximately equal, i.e. one third each for idiopathic preterm labour, 
PPROM and for the combination of maternal and fetal factors. Idiopathic preterm labour 
comprised of those cases in which no obvious maternal or fetal cause could either be 
discerned or attributed to the occurrence of spontaneous onset of labour remote from 
term. However, the main contributory factor to this preterm labour group is now 
considered to be infection as discussed in detail below (Lamont 2003) and the ‘term’ 
infection associated preterm labour (IA-PTL) will be used here on in. The PPROM 
group includes the pregnancies in which rupture of membranes occurs prior to 37 weeks 
of gestation. Finally, the maternal and fetal factors that contribute to preterm delivery 
include preeclampsia, abruption placentae and intra-uterine growth restriction (IUGR) 
that demand an early delivery to avoid any major complications to mother and/or fetus.
The known risk factors of prematurity include extremes of age and parity (nulliparity 
and grand multiparity), rapid succession of pregnancy, poor socio-economic status, race, 
maternal smoking, alcoholism and other substance misuse, poor nutrition, poor 
education, maternal anxiety, physical and sexual high risk activity, poor antenatal care 
and last, but not least, previous preterm births (Patni 1991).
1.1.2 Infection associated preterm labour
As prematurity secondary to maternal and fetal causes is inevitable, the main group to 
focus on in the fight against prematurity seems to be the infection associated preterm 
labour (IA-PTL) group, which to some extent merges into the PPROM group as 
membrane rupture could be consequential to the factors which initiated the preterm 
labour. Indeed, infections have been reported as responsible for up to 40% of all preterm 
labour cases (Lamont 2003). Furthermore, 80% of preterm deliveries occurring at less 
than 30 weeks of gestation have evidence of infection (Goldenberg, Hauth et al. 2000). 
Bacterial infection can occur in the choriodecidual space, fetal membranes, or within the 
amniotic fluid, placenta, umbilical cord or fetus. Ascending infection from the urinary 
or genital tract is considered to be the most common route of infection (Goldenberg and
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Rouse 1998), however haematogenous spread of organisms from the other sites, such as 
opportunistic pathogens like Fusobacterium nucleatum from the oral cavity, is of 
increasing interest (Bearfield, Davenport et al. 2002). In this regard, amniotic fluid 
samples from 14% women were polymerase chain reaction (PCR) positive for F. 
nucleatum. A significant association was found between detection of microbial DNA (F. 
nucleatum) and complications in previous pregnancies including miscarriage, 
intrauterine death, neonatal death, preterm delivery and premature rupture of 
membranes. However, generally in most cases it is the cervicovaginal infection 
(ascending) that progresses to intra-uterine infection and inflammation.
Several investigators have studied the role of infection in preterm labour by performing 
amniocentesis and isolating bacteria from amniotic fluid. Bobbitt and Ledger were the 
first to suggest that unrecognised amnionitis, i.e. subclinical amniotic fluid infection, 
might be causally related to preterm labour (Bobitt and Ledger 1977). The amniotic 
cavity is normally sterile and therefore the isolation of any microorganism from the 
amniotic fluid constitutes evidence of microbial invasion (Romero, Gomez et al. 2001). 
Both Gram positive and Gram negative species have been isolated and the most common 
isolates from the amniotic cavity of women with IA-PTL are Ureaplasma urealyticum, 
Fusobacterium species, Mycoplasma hominis, Escherichia coli, Group B Streptococcus 
and Gardnerella vaginalis (Hillier, Martius et al. 1988; Hillier, Krohn et al. 1991) 
However, other species are also implicated: Lactobacillus species, coagulase negative 
Staphylococcus, Enterococcus, Trichomanas vaginalis, Chlamydia trachomatis, 
Bacteroides and Peptococcus species (Gravett, Nelson et al. 1986; Hitti, Hillier et al. 
2001; Gojnic, Pervulov et al. 2005).
Similarly, unsuspected chorioamnionitis has been held responsible for a significant 
number of preterm births. Severe chorioamnionitis is found in 71% of all premature 
deliveries compared with 10% of term spontaneous deliveries (Sebire, Goldin et al. 
2001). Chorioamnionitis arises from the infiltration of leukocytes, recently shown to be 
of maternal origin (Steel, O'Donoghue et al. 2005), into the chorion and amnion in 
response to intrauterine infection. The precise molecular mechanisms by which
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infection so dramatically affects pregnancy remain undefined (Abrahams and Mor 
2005b), however, the inflammatory mediators (cytokines and chemokines) themselves 
are postulated to play a prominent role in the pathogenesis of premature labour and birth 
(Gomez, Ghezzi et al. 1995; Goldenberg and Rouse 1998). Therefore in order to reduce 
the incidence of IA-PTL, an understanding of the molecular processes which occur in 
the gestational tissues (placenta, amnion and choriodecidua) following an infection and 
how the two interact to initiate labour is required.
1.1.3 Inflammation/Cytokines and term and preterm labour
Inflammation has long been recognised as a key feature of both preterm and term labour, 
with an influx df inflammatory cells into the uterus and elevated levels of pro- 
inflammatory cytokines observed during parturition (Tamsin M Lindstrom 2005). 
Elevated concentrations of inflammatory mediators, like cytokines and prostaglandins, 
in the amniotic fluid and extraembryonic tissues occurs in pregnancies with 
demonstrable microbial invasion of the matemo-fetal interface. However, pregnancies 
without overt infection can also have elevated levels of amniotic fluid cytokines and 
prostaglandins, and it is unclear to what extent this reflects a secondary response in the 
fetal membranes to an underlying decidual infection or a physiological response as a 
normal part of labour. The elaboration of cytokines, chemokines and 
immunomodulatory proteins that support an inflammatory response in the placenta and 
gestational membranes has been investigated extensively in the context of both normal 
and abnormal pregnancy and delivery. While a robust inflammatory response 
accompanies premature labour and delivery, particularly in the presence of intrauterine 
infection, a more modest inflammatory response typifies normal term labour and labour 
has been called ‘physiological inflammation’ (Peltier 2003). Thus increased expression 
of cytokines such as interleukin-8 (IL-8) and interleukin-1 beta (IL-1P) occurs in healthy 
amnion and choriodecidua in the third trimester (compared to earlier in pregnancy) and 
after labour, supporting a role for these cytokines in the establishment and/or 
maintenance of labour irrespective of gestation (Elliott, Loudon et al. 2001).
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A link between the presence of bacterial infection at the matemo-fetal interface and the 
initiation of labour is provided by studies showing that microbial products can stimulate 
cytokine production by extraembryonic tissues (Keelan 2004) as discussed below. A 
consistent picture of how intrauterine infection and perhaps other conditions lead to 
preterm delivery is emerging. Bacterial products activate cells within the placenta, 
decidua, chorion and amnion leading to the production of pro-inflammatory cytokines 
such as interleukin-6 (IL-6), tumour necrosis factor-alpha (TNFa) and IL-1P; 
chemokines such as IL-8 and macrophage inflammatory protein-1 alpha (MIP-la) ; and 
immunosuppressive or anti-inflammatory cytokines such as interleukin-10 (IL-10) and 
interleukin-4 (IL-4) (Erroi, Fantuzzi et al. 1993; Deetz, Jagielo et al. 1997) . Some of 
these mediators are also postulated to contribute to the normal maintenance of 
pregnancy and disruption of the delicate balance of these cytokines at the matemo-fetal 
interface by bacteria or other factors is postulated to trigger a cascade of events leading 
to cyclo-oxygenase (COX2) activity and the production of prostaglandins, that cause 
uterine contractions thereby activating the parturition mechanism prematurely (Ville 
2001). Elevated levels of proinflammatory mediators like IL-6, IL-8 and TNFa and IL- 
lp in patients with chorioamnionitis (+/- infection) are reported by many groups to occur 
in the amniotic fluid, maternal serum, cervical secretions, placenta, fetal membranes and 
other compartments of the placento-matemal unit (Denison, Kelly et al. 1998; Laham, 
Brennecke et al. 1999; Dowd, Laham et al. 2001).
IL-6: IL-6 is a proinflammatory cytokine which, during the early phase of inflammation, 
acts to activate and mature neutrophils and macrophages, and to promote differentiation 
of natural killer cells. These are the leukocytes that invade cervical and endometrial 
tissue prior to labour and contribute to labour progression (Osman, Young et al. 2003). 
IL-6 also acts as a growth factor and can stimulate the expression of oxytocin receptors 
on myometrial cells to increase responsiveness to oxytocin (Rauk, Friebe-Hoffmann et 
al. 2001). Plasma IL-6 is significantly elevated in women with premature labour 
compared to gestationaly matched, non-labouring controls (Laham, Rice et al. 1993).
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Vaginal levels of IL-6 are also significantly elevated among women with threatened 
preterm labour and cervico-vaginal concentration of IL-6 has been found to be a good 
predictor of preterm delivery (Torbe and Czajka 2004). Stimulation of explants of 
amnion, placenta or choriodecidua with lipopolysaccharide (LPS) from Gram negative 
bacteria leads to elevated IL-6 levels in culture supernatants (Laham, Brennecke et al. 
1996) thereby linking IL-6 production with a microbial stimulus.
IL-6 is also a physiological constituent of amniotic fluid and its production by 
gestational tissues has been described to not only be regulated by exposure to LPS but 
by mode and time of delivery. IL-6 was released from all choriodecidual and placental 
explants both prior to labour and after term labour and delivery with levels significantly 
higher in the laboured group in both choriodecidual and placental explants. In contrast, 
IL-6 was detected in only 33% of amniotic explant cultures prior to onset of labour at 
term but from 100% amniotic explants after term labour and delivery, and again mean 
IL-6 levels were higher in the latter group (Laham, Brennecke et al. 1996).
Thus, microbial product mediated production of IL-6 in intrauterine tissues has been 
proposed as an important etiological factor contributing to preterm labour (Casey, Cox et 
al. 1990), but IL-6 may also play a role in term labour onset and/or maintenance (Cox, 
King et al. 1993). It has been proposed that, following cervical ripening and dilatation, 
the decidua lining the fetal membranes is exposed to vaginal-cervical fluid and activated 
by bacterial toxins present in the fluid. This activation of the decidua results in the 
release of cytokines, such as IL-6. If this model is correct, IL-6 release may be an epi- 
phenomenon of the onset of human labour and delivery both at term and preterm 
gestations.
IL-8: Like IL-6, the a  chemokine IL-8, is postulated to have a role in preterm labour as 
well as in normal labour at term. Enhanced expression of chemokines such as IL-8 
presumably recruits infiltrating leukocytes into the fetal membranes thereby amplifying 
the inflammatory process and hastening membrane rupture and delivery. IL-8 is notable 
for its selective chemotaxis, degranulation and activation of neutrophils into tissue 
stroma. It is present within the uterus, cervix, placenta, myometrium, amnion and
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choriodecidua: explants of amnion, placenta and choriodecidua all release IL-8 
constitutively with choriodecidual explants producing significantly greater levels of IL-8 
than amnion or placenta (Laham, Brennecke et al. 1997). The concentration of IL-8 
tends to increase in the third trimester, particularly in the amniotic fluid, choriodecidua 
and uterus (Laham, Rice et al. 1993; Laham, Brennecke et al. 1997; Laham, Brennecke 
et al. 1999).
A statistically significant increase in IL-8 protein and mRNA expression has been shown 
to occur in the amnion in association with parturition at term (Elliott, Allport et al. 
2001). However, in another study, spontaneous onset of labour, irrespective of the 
gestation and eventual mode of delivery, was not associated with any significant changes 
in IL-8 release from human gestational tissues, including amnion, compared to non- 
laboured tissues. Similarly, chorioamnionitis did not impact significantly on IL-8 release 
(Laham, Brennecke et al. 1997; Laham, Brennecke et al. 1999). However upon 
stimulation with lipopolysaccharide (LPS) IL-8 release is significantly increased from 
both choriodecidual and placental explants but not from amniotic explants (Laham, 
Brennecke et al. 1999).
Despite the general lack of significant increase from gestation-associated tissues, IL-8 
concentrations are increased in the amniotic fluid in association with labour at term with 
respect to the gestational-age matched controls. However, although the concentration of 
IL-8 in amniotic fluid obtained from women in preterm labour was higher it was not 
statistically different from that in amniotic fluid obtained from gestational aged-matched 
non-labouring controls. Thus whilst microbial stimulation can induce production of a 
relevant mediator by appropriate tissues most of the data relating to IL-8 production is 
consistent with the suggestion that IL-8 release is an early event in chorioamnionitis that 
precedes the appearance of clinically overt symptoms. Moreover, IL-8 might be 
particularly relevant to events surrounding cervical ripening. The IL-8 concentration in 
cervical secretions at 28 weeks of gestation was significantly higher in women who went 
on to deliver preterm compared to women who continued until term and there was a 
greater than five-fold increase from 18 to 28 weeks in this subset of women (Dowd, 
Laham et al. 2001).
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Cervical ripening is a result of an extensive remodelling process in the cervical tissue 
during pregnancy and labour. It is recognized as softening and dilatation of the cervical 
canal, and starts as a slow process during pregnancy, becoming rapid, as labour 
approaches. Cytokines have been postulated as possible mediators of the cervical 
ripening. Levels of mRNA for IL-8, IL-6 and granulocyte colony-stimulating factor (G- 
CSF) are up-regulated in ripe postpartum cervical tissue compared to unripe tissue 
(Sennstrom, Ekman et al. 2000). Likewise, the release of these cytokines by cervical 
tissue increases from the non-pregnant to the term-pregnant state with a further increase 
at delivery. For example, IL-8 concentrations increased 4-fold from the non-pregnant to 
the term-pregnant and a further 10-fold to the postpartum state. IL-8 immunoreactivity 
was identified in the epithelia of cervical tissue from pregnant women and was most 
pronounced in the epithelia and stroma of tissue collected postpartum (Sennstrom, 
Ekman et al. 2000). Thus cervical ripening is an inflammatory process with a central 
role mediated by IL-8.
TNFa: TNFa is a 17-kD pleiotropic peptide implicated in mediating the cellular events 
that occur at labour, both term and preterm. This potent proinflammatory cytokine 
stimulates the increased synthesis of prostaglandins by gestation-associated tissues both 
at term and preterm (Mitchell, Trautman et al. 1993) and is postulated to play an 
etiological role in the onset and/or maintenance of labour (Rice 1990). LPS-treated 
explants of choriodecidual and placental tissue release significantly greater levels of 
TNFa than unstimulated samples.
IL-1: IL-1 is also implicated in the onset and/or maintenance of term and preterm 
labour. Its biological activity has been attributed to two polypeptides, IL-1 a and IL-1 p, 
as well as the opposing effect of the IL-1 receptor antagonist protein (IL-lra). It is 
known that whereas IL-1 p is present in the placenta and stimulates prostaglandin 
formation (Mitchell, Romero et al. 1991), there is a predominance of IL-1 a and IL-lra in 
the human amniotic fluid and decidua (Romero, Brody et al. 1989). Similar to IL-6, IL-8 
and TNFa, IL-1 a concentrations did not change significantly in maternal plasma and
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amniotic fluid with spontaneous term labour and delivery (Laham, Brennecke et al. 
1996). However IL-la was released in detectable amounts from human placental and 
choriodecidual explants in association with term labour and delivery compared to non­
labour tissues. LPS stimulated a significant increase in IL -la from human placental 
explants from both term non-laboured and term laboured tissues. Levels of IL-la and 
IL-lp are significantly elevated in cervicovaginal fluid from women with bacterial 
vaginosis (Kalinka, Wasiela et al. 2003) suggesting that like cytokines already discussed 
above, they also might be linked with preterm labour. Indeed preterm parturition can be 
triggered in rabbits by intra-amniotic injections of IL-la or TNFa (Bry and Hallman 
1993).
Evidence for a role for inflammatory cytokines in IA-PTL is also provided by genetic 
studies. It has been proposed that genetic predisposition to immune hyper­
responsiveness to an infectious insult might result in overproduction of cytokines such 
as TNFa and IL-1 (Dizon-Townson 2001). This genetic predisposition to cytokine over­
expression might manifest on either the maternal, fetal, or both sides of the maternal- 
fetal interface. A polymorphism in intron 2 of the IL-lra gene (IL1RN * 2), was 
associated with a blunted proinflammatory IL-lp response to abnormal vaginal flora and 
the carriers of this polymorphism had a decreased susceptibility to infection-associated 
preterm birth (Gene, Onderdonk et al. 2004). This highlights the role of IL-1 p in the 
aetiology of preterm labour.
The apparent association of proinflammatory cytokines and chemokines with labour has 
led to an interest in anti-inflammatory cytokines as potential in vivo regulators of 
cytokine activity and consequently, as possible therapeutic agents. Anti-inflammatory 
cytokines, like IL-10, might be involved in protecting the fetal allograft throughout 
pregnancy and at parturition (Denison, Kelly et al. 1998). Anti-inflammatory effects for 
IL-10 were found on choriodecidual explants, but not in the adjacent amnion where, in 
contrast, it had pro-inflammatory actions (Mitchell, Simpson et al. 2004). IL-10 was 
expressed by explants of placenta from all trimesters of normal pregnancies with its 
expression significantly diminished in term placental tissues collected before the onset
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of labour and term labour had no significant effect on placental IL-10 levels. The down- 
regulation of IL-10 near term might be an important mechanism underlying the subtle 
changes associated with the initiation of normal parturition (Hanna, Hanna et al. 2000). 
Furthermore in animal models (rhesus monkeys) IL-10 inhibited IL-lp induced uterine 
activity, possibly by decreased prostaglandin production (Sadowsky, Novy et al. 2003). 
IL-4, although considered an anti-inflammatory agent, was found to be elevated in 
women with preterm labour and delivery, particularly in association with 
chorioamnionitis in one study (Dudley, Hunter et al. 1996). This could indicate a 
proinflammatory role for IL-4 or mark a failed attempt to control proinflammatory 
cytokines by upregulating this anti-inflammatory cytokine. Transforming growth factor- 
beta 2 (TGFp2), also known to have anti-inflammatory properties, has been shown to 
prevent the preterm delivery induced by IL-la and TNFa in rabbits (Bry and Hallman 
1993) and can downregulate TNFa release from amniochorion in invitro models 
(Fortunato, Menon et al. 1997).
In addition to those discussed in detail above, other cytokines are postulated to play 
pivotal roles in immune recognition, acceptance of the fetal allograft and maintenance of 
pregnancy alongside parturition. Interleukin 18 (IL-18), for example, is a 
proinflammatory pleiotropic cytokine that has been implicated in the host defence 
against infection. IL-18 is increased in amniotic fluid in cases of microbial invasion of 
the amniotic cavity in both term and preterm labour and is detectable in the amniotic, 
maternal, and fetal compartments (Pacora, Romero et al. 2000). Other mediators such as 
monocyte chemotactic peptide-1 (MCP-1) and RANTES (Regulated upon Activation, 
Normal T cell Expressed and presumably Secreted) also appear to have a role in 
inflammatory responses within gestational tissues, but their secretion and regulation 
within the third trimester uterus is less well defined (Denison, Kelly et al. 1998).
A critical role for pro-inflammatory cytokines in labour could be the induction of 
prostaglandins (PG). PG released by the membranes in response to stretch and the 
actions of pro-inflammatory cytokines act not only upon the myometrium and cervix, 
but might also exert paracrine/autocrine effects on cell viability and matrix protein
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integrity. The localisation and regulation of enzymes, responsible for converting PGH2 
to bioactive prostanoids such as PGE2 and PGF2tt, are being studied in the myometrium 
and cervix, particularly in the context of cytokine interactions. Furthermore gestational 
tissues are sources of PGD2 and PGJ2 and their derivatives, but the regulation of 
production of these prostaglandins has yet to be studied in any detail and their actions, 
which could include apoptosis and anti-inflammatory activity, remain poorly defined 
(Keelan 2004).
Whilst the published literature suggests that inflammatory cytokines are elevated in 
preterm labour and that cytokines can account for the histological changes that 
characterise chorioamnionitis, it is essential to establish a causal link between the 
bacteria known to infect the gestation associated tissues and the consequent cascade of 
events leading to labour. An ex vivo system was designed to model fetal membrane 
biology and immunology, i.e. linking cytokine response and infection (Keelan 2004). 
Studying membranes from term delivery (non-laboured, caesarean section) exposed to 
LPS on either the maternal or fetal side revealed that accumulation of inflammatory 
mediators in the amniotic cavity can arise in the absence of intra-amniotic infection as a 
result of activation of the fetal membranes secondary to decidual activation. Elevated IL- 
6 levels in amniotic fluid were predicted by this model to be a good marker of 
intrauterine infection, as is observed clinically. TNFa can cross the membrane barrier, 
albeit with low efficiency, explaining its poorer diagnostic profile.
From the above it is clear that many of the processes necessary for term or preterm 
labour (e.g. remodelling of the cervix, rupturing of the membranes and myometrial 
contractions) are initiated/mediated by inflammatory cytokines. Many of the cell types 
that are sources of these cytokines and mediate these remodelling events are also 
involved in the early and crucial events triggering host defences against invading 
pathogens and so are implicated in infection associated preterm labour. In this regard, 
Nuclear factor kappa B (NF-kB) has been implicated by a number of groups in the 
regulation of pro-inflammatory cytokine and prostaglandin production by gestation-
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associated tissues. NF-kB is a transcription factor family classically associated with 
inflammation. For example, NF-kB is essential for basal and IL-lp stimulated IL-8 
production by primary amnion cells and NF-kB activity can be detected in amnion only 
after labour has occurred (Elliott, 2001, Allport-2001). Thus NF-kB might have a critical 
role in signalling pathway(s) that increase inflammatory cytokine production and 
antimicrobial peptides in gestation-associated tissues (Ulevitch 2004). Similarly studies 
by Tamsin and Bennett (Allport, Pieber et al. 2001; Tamsin M Lindstrom 2005) suggest 
a role for NF-kB in the physiology and pathophysiology of labour. NF-*B activity 
increases with labour onset and is central to multiple pro-labour pathways. Premature or 
aberrant activation of NF-kB may thus contribute to preterm labour
How bacterial pathogens interact with cells of the reproductive tract to initiate 
inflammatory processes and cytokine production at the matemo-fetal interface in term 
and preterm labour are poorly understood. Recent advances in developmental biology 
and functional genomics have seen dramatic advances in our understanding of signalling 
pathways involved in innate immune defences and have led to the discovery of a family 
of receptors, the Toll-like receptors (TLRs), which are now of great interest to those who 
study the immunology of gestation-associated tissues.
1.2 TOLL LIKE RECEPTORS
Toll-like receptors (TLR) have emerged as key upstream mediators of inflammation at 
many tissue sites in humans and other organisms. TLRs are a family of proteins, 
consisting of ten type 1 transmembrane receptor proteins (Beutler and Poltorak 2000) in 
humans and thirteen in mice. (Tabeta, Georgel et al. 2004). It is not known if a recently 
identified 11th member of this family is functional in humans (Zhang, Zhang et al. 2004).
‘Toll\ derived from the German word for “amazing” or “mad”, was first discovered in 
the fruit-fly Drosophila melanogaster as a plasma membrane protein with a role in 
development of dorsoventral polarity during embryogenesis (Hashimoto, Hudson et al.
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1988). Later, Toll was also found to have a role in the fly’s immunity to fungal 
infections (Lemaitre, Nicolas et al. 1996). Upon infection of Drosophila the Toll ligand 
Spatzle is processed into a biologically active form which binds to Toll and induces a 
signalling cascade resulting in the production of the antimicrobial peptide drosomycin 
(Lemaitre, Nicolas et al. 1996; Levashina, Langley et al. 1999).
The first mammalian TLR, so called because of its sequence homology to the 
Drosophila melanogaster gene Toll (GrohoTs 2005), was identified in 1997 (Medzhitov, 
Preston-Hurlburt et al. 1997). Given the apparent conservation of this receptor type 
through evolution, it is perhaps not surprising that all animals studied, including goldfish 
and chickens, have TLRs (GrohoTs 2005). The presence of homologous receptors in 
plants indicates that they are of ancient evolutionary origin and, after the defensins, 
might be the oldest components in the immune system (Goldstein 2004).
The TLR family is the best-characterised class of mammalian pattern recognition 
receptors (PRRs). The pattern recognition strategy of these receptors is based upon the 
detection of a limited set of conserved molecular patterns that are unique to the 
microbial world. The targets of pattern recognition, sometimes called pathogen- 
associated molecular patterns (PAMPs) signal to the host the presence of infection 
(Janeway and Medzhitov 2002). TLRs are expressed by cells involved in innate 
immunity and enable recognition of invading microbes and initiation of anti-microbial 
activity. Whilst TLRs are now recognised to play a crucial role in the regulation of 
immune responses, the factors that regulate TLR expression and function are poorly 
understood.
All members of mammalian TLRs described to date share a unique structure comprising 
of three parts: a highly homologous cytoplasmic domain, similar to the IL-1 receptor 
with which it shares a conserved homophilic domain of approximately 200 amino acids 
known as the Toll/IL-1 Receptor domain (TIR) (Cook, Pisetsky et al. 2004); a very short 
transmembrane domain; and an extracellular portion consisting of leucine-rich repeats 
(Wright 1999) and one or two cysteine-rich regions (Cario 2003) (Figure 1.1).
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Expression of TLRs occurs predominantly at the plasma membrane but these receptors 
are also expressed within intracellular phagolysosomes.
TLRsl, 2, 4, 5 and 6 tend to specialise in the recognition of bacterial products that are 
present on the outer surfaces of the microorganisms whereas TLRs3, 7, 8 and 9, 
specialise in recognising nucleic acids, especially those of viral origin, and are localised 
intracellularly (Ulevitch 2004). Self/non-self discrimination of nucleic acids is mediated 
not so much by the molecular nature of the ligands as by their accessibility to the TLRs 
(Iwasaki and Medzhitov 2004). These TLRs (3, 7, 8 and 9) are typically localised in 
intracellular compartments, especially late endosomes-lysosomes, which are not 
normally accessible to host nucleic acids (Lund, Sato et al. 2003; Diebold, Kaisho et al. 
2004; Lund, Alexopoulou et al. 2004).
The extracellular domains of TLRs, usually composed of 24-29 amino-acid repeats, 
function as sentinels for ‘molecular patterns’ on different classes of pathogens. Ligands 
for TLRs include exogenous/microbial (e.g. bacterial/viral RNA/DNA, 
lipopolysaccharide and lipopeptides) as well as endogenous/host-derived (human heat 
shock proteins 60, 70 and host RNA, P-defensins and oxidised lipids) stimuli (Vabulas, 
Ahmad-Nejad et al. 2002; Wan, Zhou et al. 2004). With the exception of TLR10, 
microbial ligands for each of the human TLR family members have been described, as 
shown in Table 1.1. The presence of endogenous ligand, i.e. various host-derived 
products released during tissue damage or “danger signals” (Matzinger 2002), indicates 
a possible role for TLR signalling pathways in normal physiological phenomena and are 
postulated to cause sterile inflammation (Ulevitch 2004).
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individual TLRs. (Elke Cario, 2003)
1-17
TLR Gene location Microbial 
Ligands 
(natural and 
synthetic)
Natural
Ligands
Known
Activation
Cascades
TLR1 
(TLR 2)
Chromosome-4 Triacetylated
lipoproteins
Unknown
TLR 2 Chromosome-4 Gram positive 
Peptidoglycan, 
Lipopeptides (di 
and tri acyl), 
Lipoarabinomannan 
, Lipotechoic acids 
(Mycoplasma), 
Zymosan (fungal 
hyphae and conidia)
Heat shock 
protein 70
MyD88 dependent 
TIRAP
TLR 3 Chromosome-4 Double stranded 
viral RNA 
Polyinosine- 
polycytidilic acid 
(poly I:C)
Host RNA MyD88 independent 
TRIF/TICAM
TLR 4 Chromosome-9 Gram negative 
lipopolysaccharide
Taxol
Neutrophiles 
Elastase, Heat 
shock protein 
60,Fibronectin 
A
MyD88 dependent 
TIRAP; MyD88 
independent 
TRIF/TICAM/TRAM
TLR 5 Chromosome-1 Bacterial flagellin MyD88 dependent 
IRAK
TLR6 
(TLR 2)
Chromosome-4 Zymosan (fungal 
hyphae and 
conidia), 
Diacetylated 
Lipoproteins
Unknown
TLR 7 Chromosome-X Single stranded
RNA-Small
synthetic
compounds- R848,
Loxaribine,
Bropirimine
MyD88 dependent 
IRAK
TLR 8 Chromosome-X Single stranded
RNA-Small
synthetic
compounds- R848, 
Bropirimine
MyD88 dependent 
IRAK
TLR 9 Chromosome-3 Unmethylated CpG 
DNA
MyD88 dependent 
IRAK
TLR 10 Chromosome-4 Unknown Unknown
TLR 11 Chromosome-
unknown
Profilin 
(Toxoplasma 
gondii)
MyD88 dependent 
IRAK
Table 1.1 Chromosome location and ligands fo r TLRs and their known signalling pathways.
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TLR4, the first human Toll-like receptor to be well characterised, is a receptor for LPS 
of Gram-negative bacteria (Medzhitov, Preston-Hurlburt et al. 1997) (Poltorak, He et al. 
1998) (Hoshino, Takeuchi et al. 1999; Qureshi, Lariviere et al. 1999). It was found to be 
in the target region of chromosome 4 in mice and this might explain the origin of its 
name. Recently, a TLR4 polymorphism (Asp299Gly) was shown to be associated with 
impaired TLR4 receptor function and an increased likelihood of Gram-negative sepsis 
(Agnese, Calvano et al. 2002). TLR4 mediated responses generally require additional 
molecules, such as CD 14, lipopolysaccharide binding protein (LBP) and MD2 to initiate 
the signalling cascade. The latter is an apoprotein with a secreted leucine-rich repeat 
domain that is required for surface expression and LPS-regulated activation of TLR4. 
MD2 exists both in soluble form and as a glysosylphosphatidylinisitol anchored (GPI- 
anchored) protein. TLR4 forms a complex with MD2 leading to translocation of nuclear 
factor-kappaB (NF-kB) to the nucleus and cytokine production in response to LPS 
stimulation (Shimazu, Akashi et al. 1999).
In addition to sensing LPS, TLR4 mediates signals initiated by other exogenous 
compounds like respiratory syncytial virus protein F, and several endogenous proteins 
that may be present during inflammation such as heat shock protein 60 and the 
proinflammatory extra domain A of fibronectin (Wan, Zhou et al. 2004). A TLR-related 
protein, called RP105, was identified in B cells and acts as both a LPS sensor and a 
regulator of B cell proliferation (Yazawa, Fujimoto et al. 2003). However, more 
extensive expression of RP105 has been described recently and RP105 might be a 
negative regulator of TLR4 activity. Like TLR4, RP105 requires an MD2-related 
protein, MD1, for its surface expression. (Divanovic, Trompette et al. 2005).
TLR2 has the broadest specificity of the TLRs since it can recognise Gram-positive, 
Gram-negative and mycobacterial associated lipoproteins, Gram-positive peptidoglycan 
and lipoteichoic acid, and fungal zymosan (Yoshimura, Lien et al. 1999). A Arg753Gln 
TLR2 polymorphism in humans has been associated with increased susceptibility to 
infection with Staphylococcus aureus (Lorenz, Mira et al. 2000). TLR2 knockout mice 
are similarly susceptible and this demonstrates the role of TLR2 in responses to bacterial
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lipoproteins. TLR2 recognition of some microbial products appears to be dependent 
upon the formation of heterodimers with either TLR1 or TLR6 (Takeuchi, Kawai et al. 
2001; Krutzik, Ochoa et al. 2003). TLR1 recognise bacterial triacylated lipoproteins like 
peptidoglycan (Takeuchi, Sato et al. 2002), while TLR2/TLR6 complexes recognise 
mycoplasmal diacylated lipoproteins like lipotechoic acid, as well as fungal zymosan 
(Takeuchi, Kawai et al. 2001; Morr, Takeuchi et al. 2002).
TLR3 binds viral double stranded RNA (dsRNA). On stimulation with its synthetic 
ligand, polyinosine-polycytidilic acid (poly I:C) proinflammatory cytokines and 
chemokines, particularly type I interferons (IFNa/p) are released (Schaefer, Fahey et al.
2005). This is the only TLR which utilises MyD88 independent TRIF/TICAM signalling 
pathway. This contrasts with all other TLRs which have MyD88 dependent cascades.
TLR5 is a signalling mediator of bacterial flagellin, a principal component of bacterial 
flagella, and may play a role in resistance to Salmonella infection. Mammalian TLR5 
recognizes bacterial flagellin from both Gram-positive and Gram-negative bacteria and 
upon its activation the receptor mobilizes NF-*B and stimulates TNFa production 
(Hayashi, Smith et al. 2001). A common stop codon polymorphism in the ligand-binding 
domain of TLR5 (Arg392STOP) is associated with susceptibility to pneumonia caused 
by Legionella pneumophila, a flagellated bacterium, due to lack of flagellin-mediated 
signalling (Hawn, Verbon et al. 2003).
TLR7 and 8 recognise small antiviral molecules and detect single stranded viral RNA 
like that of influenza (Lund, Alexopoulou et al. 2004). There are several synthetic 
ligands for the stimulation of TLR7/8 such as R848 (antiviral synthetic compound), 
loxoribine, bropirimine, and single stranded poly-oligonucleotides. Both TLR7 and 8 
independently confer responsiveness to R848, which is an imidazoquinoline compound 
with antiviral activity. Although TLR7 and TLR8 are phylogenetically (Figure 1.2) and 
structurally related, their relative functions are largely unknown. The role of TLR7 has 
been established using TLR7-deficient mice and small molecule TLR7 agonists. TLR 
agonists selective for TLR7 or TLR8 were used to determine the repertoire of human
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innate immune cells that are activated through these TLRs: TLR7 agonists directly 
activated purified plasmacytoid dendritic cells and, to a lesser extent, monocytes, 
whereas TLR8 agonists directly activated purified myeloid dendritic cells, monocytes, 
and monocyte-derived dendritic cells. Accordingly, TLR7 selective agonists were more 
effective than TLR8 selective agonists at inducing IFN-a and IFN-regulated 
chemokines. In contrast, TLR8 agonists were more effective at inducing 
proinflammatory cytokines and chemokines, such as TNFa, IL-12, and MIP-la 
(Gorden, Gorski et al. 2005). Thus TLR7 and TLR8 agonists differ in their target cell 
selectivity and cytokine induction profile.
TLR9 detects unmethylated CpG (deoxycytidine-deoxyguanosine dinucleotide) motifs 
that occur in microbial DNA (Krieg 2006). TLR9 is expressed predominantly by 
plasmacytoid dendritic cells and B cells. TLR9 detects a pattern that is present in the 
DNA of invading intracellular pathogens but is not present in mammalian DNA to 
trigger a proinflammatory response.
TLR10 is an orphan member of the human TLR family (Hasan U, 2005). Genomic 
studies indicate that TLR 10 is in a locus that also contains TLR1 and TLR6, both known 
to function as co-receptors for TLR2 and to which TLR 10 is phylogenetically most 
closely related (Figure 1.2). Interestingly TLR 10 not only forms homodimers but also 
heterodimerises with TLR1 and TLR2. Unlike widely expressed TLR1 and TLR6, 
TLR 10 expression is more restricted and has been detected in B cells and weakly 
expressed in plasmacytoid dendritic cells (Homung, Rothenfusser et al. 2002). Although 
the specific ligand for TLR10 is not yet identified, functional activity of TLR10 has been 
demonstrated using a recombinant CD4-TLR10 molecule (Hasan, Chaffois et al. 2005).
TLR11 existence and/or function in humans remain unclear. Transcripts for TLR11 are 
highly expressed in the urinary tract of mice, thus contrasting with the expression 
patterns of other TLRs (Zhang, Zhang et al. 2004) and suggesting that TLR11 might be 
involved in responses to uropathogenic bacteria. Recently, a Toxoplasma gondii-derived 
profilin-like protein has been identified as a ligand for murine TLR 11 (Yarovinsky, 
Zhang et al. 2005). However, the human TLR 11 gene contains several stop codons
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suggesting that TLR 11 might not be expressed and/or functional in humans (Zhang, 
Zhang et al. 2004).
-----------  hTLR1
----------------------- hTLR10
  hTLR6
  hTLR2
----------------------------------  hTLR4
hTLR5
-----------  hTLR7
  hTLR8
------------------ hTLR9
hTLR3
Figure 1.2 Phylogenetic tree o f the human toll-like receptor family (Chuang and Ulevitch 2000).
1.2.1 Mechanism of action of TLR
The innate immune system represents the immunological first line of defence against 
invading pathogens through the ability to distinguish between what is non-infectious self 
and infectious non-self (Medzhitov and Janeway 2002). Each TLR forms either a 
homodimer or heterodimer in the recognition o f a specific or set of specific molecular 
determinants present on microorganisms. The specificity of TLRs and other innate 
immune receptors cannot be changed rapidly, so these receptors must recognise patterns 
that are constantly present on threats, not subject to mutation, and highly specific to 
threats (i.e. not normally found in the host). Patterns that meet this requirement are 
usually critical to the pathogen’s function and not readily eliminated or changed through 
mutation; and thus are said to be evolutionary conserved (Medzhitov R 2000).
Ligation o f a TLR by microbial or endogenous products results in an inflammatory 
immune response characterised by the production of cytokines and anti-microbial factors 
(Medzhitov and Janeway 1997). Furthermore, through the regulation of co-stimulatory
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molecules, TLRs might also facilitate the development of adaptive immune responses 
(Medzhitov and Janeway 1997). Thus while individual TLRs respond to limited ligands, 
collectively the family of TLRs can respond to a wide range o f products associated with 
bacteria, viruses, fimgi and parasites as shown in Figure 1.3. It is not clear how a 
restricted family of receptors has the capacity to recognise the wide spectrum of 
microbial stimuli known to exist. Co-transfection of different TLRs might lead to either 
enhancement or inhibition of recognition of particular PAMPs (Ozinsky, Underhill et al. 
2000), suggesting that cellular responses to PAMPs are dependent on the total repertoire 
of TLRs displayed on a cell, necessary cofactors, and the levels of each protein present.
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Figure 1.3 Ligands and phylogenetic tree o f human Toll-like receptors as shown on a dendritic cell 
(Kaisho 2004).
The requirement for TLR cooperation is supported by the finding that TLR2 needs a 
partner to activate TNFa production in macrophages. Dimerisation of the cytoplasmic
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domain of TLR2 does not induce TNFa production in macrophages, whereas similar 
dimerisation of the TLR4 cytoplasmic domain does. Thus, the cytoplasmic tails of TLRs 
are not functionally equivalent, with certain TLRs requiring assembly into heteromeric 
complexes, whereas others are active as homomeric complexes. The best example of this 
is elicited by the TLR2 as discussed earlier (Takeuchi, Kawai et al. 2001; Krutzik, 
Ochoa et al. 2003). Thus TLRs can establish a combinatorial repertoire to discriminate 
among the large number of pathogen-associated molecular patterns found in nature.
1.2.2 TLR signalling pathways
Each TLR has distinct extracellular specificity but all receptors signal through shared 
pathways. Consequently, following ligation with their specific ligands, TLRs elicit 
different but often overlapping immune responses leading to transcriptional activation of 
inflammatory genes. The common cytoplasmic TIR signalling domain mediates the 
interaction between TLRs and a family of TIR-containing adaptors that recruit receptor- 
associated kinases as shown in Figure 1.4a&b and Table 1.1. Currently four intracellular 
proteins function as adaptors for TLRs: myeloid differentiation factor 88 (MyD88, the 
most commonly used and initially thought to be the crucial mediator of TLR signalling) 
(Takeuchi, Takeda et al. 2000), TIR domain containing adaptor inducing IFN-p (TRIF), 
TRIF related adaptor molecule (TIRP/TRAM) and MAL (MyD88-adapter-like). These 
adaptors link the receptors via a series of kinases (e.g. mitogen activated protein kinase 
(MAPK) and IkB kinases) (Henneke and Golenbock 2004) to the transcriptional 
machinery typically via NF-kB and AP-1 (activating protein-1) which in turn leads to the 
production of several different cytokines.
As an example, MyD88 contains a TIR domain within its C-terminal and a death domain 
(DD) within its N-terminal (Fitzgerald, Palsson-McDermott et al. 2001) (Hardiman, 
Rock et al. 1996). Following ligation of a TLR by its ligand, MyD88 becomes associated 
with the intracellular domain of the receptor through a TIR-TIR interaction (Sato, 
Sugiyama et al. 2003). In turn MyD88, through its DD, recruits and activates the DD- 
containing serine/threonine kinase IL-1-receptor associated kinase (IRAK) (Wesche, 
Henzel et al. 1997). IRAK then dissociates from the receptor complex and becomes
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associated with TNF-receptor associated factor (TRAF-6) (Cao, Xiong et al. 1996). 
TRAF-6 then dissociates from this complex and associates with another complex 
containing TGF(3 activated kinase (TAK-1). TAK-1 is thus activated, which in turn 
activates the MAPK signalling pathways including the IkB kinase kinase (IKK) 
complex. The kinase activity of this complex is modulated by its IKKy subunit, the 
transcription factor NF-kB essential modulator (NEMO). IKK-mediated 
phosphorylation of IkB unmasks the nuclear localisation domain of NF-kB (Cook, 
Pisetsky et al. 2004). After its translocation into the nucleus, NF-kB activates multiple 
cytokine genes (Takaesu, Kishida et al. 2000) (Takaesu, Ninomiya-Tsuji et al. 2001) 
resulting in the production of cytokines, chemokines and antimicrobial peptides.
Experiments using MyD88 deficient cells revealed that NF-kB and JNK (c-Jun N- 
terminal kinase) activation induced by TLR3 and TLR4, unlike other TLRs, was not 
completely abolished, but was instead delayed (Adachi, Kawai et al. 1998). Thus some 
TLRs signal via MyD88 independent pathways (Figure 1.4a). In addition to MyD88, 
TLR4 can associate with TRIF, which via its N-terminal end can directly bind TRAF-6 
and subsequently activate NF-kB (Sato S, 2003). The production of type-1 interferons 
(IFNa and IFNP) via stimulation of TLR4 and TLR3 with LPS and dsRNA respectively 
utilises MyD88 independent pathways and expression of IFN-inducible genes (Akira 
and Takeda 2004), as a result of TRIF, through TBK-1 (TANK-binding kinase-1), and 
activation of the transcription factor, IFN regulatory factor (IRF3/7) (Han, Su et al. 
2004). Further analysis of other TLR pathways has revealed additional MyD88- 
independent mechanisms. TLR2 interacts with RaclGTPase initiating a signalling 
cascade that also results in NF-kB translocation and possibly other non-transcriptional 
responses (Arbibe, Mira et al. 2000). Thus, while TLRs share many features, some 
unique properties of individual receptors can have a significant impact on 
immunological and functional outcomes.
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‘Ligand specificity’ primarily determines which TLR is activated in a given cell but the 
presence of other TLRs and the secondary signalling pathways engaged provide a 
further level of control of the tissue response to a particular PAMP. Additional 
molecules such as CD 14, MD2 and LBP have also been found to affect the activity and 
response of TLRs (especially TLR4).
The importance of intact TLR signalling pathways is highlighted by genetic studies of 
human primary immunodeficiencies caused by germ line mutations in genes encoding 
molecules involved in cell signalling downstream from TLRs (Ku, Yang et al. 2005). 
The cells of subjects with anhidrotic ectodermal dysplasia with immunodeficiency (have 
developmental anomalies of skin appendages and a broad spectrum of infectious 
diseases) show a broad defect in NF-kB activation, with an impaired, but not abolished 
response to a large variety of stimuli including TLR agonists. However patients with 
autosomal recessive amorphic mutations in IRAK4 present a purely immunological 
syndrome with more restricted defects. In these subjects, the NF-kB and MAPK 
mediated induction of inflammatory cytokines in response to TLR agonists is impaired. 
The patients present with a narrow range of pyogenic bacterial infections that become 
increasingly rare with age.
1.3 DISTRIBUTION OF TLRs IN HUMAN TISSUES
Whilst leukocytes within the peripheral blood are relatively well studied there is much 
interest in the contribution of these receptors to normal and pathological processes in 
various tissues. Typically, TLR expression is monitored by investigation of mRNA 
and/or protein expression with functional responses to TLR agonists much less 
frequently studied. TLR distribution in a broad range of tissues from adult humans has 
been examined using quantitative PCR (Zarember and Godowski 2002; Nishimura and 
Naito 2005). To facilitate comparison between tissues in Zarember’s study, all samples 
were normalised to the expression of the particular TLR in spleen (spleen = 1). The
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tissues involved in immune function (e.g., spleen, peripheral blood leukocytes) displayed 
the most diverse repertoire of TLR transcripts, as did those expected to encounter 
microbes (e.g., lung, small intestine and colon). TLR3 and TLR5 were expressed 
ubiquitously, whereas RP105 and TLR 10 were more restricted. Of particular interest the 
placenta expressed an abundance of TLR3 (4.99x more than spleen), TLR5 (1.75x) and 
TLR7 {1.78x). TLR1, TLR2, TLR4 and TLR8 were also expressed in placenta but in 
lesser amounts than in the spleen. As TLR expression by mucosal tissues is important 
for host defence against pathogens (Gewirtz 2003; Yuan and Walker 2004), most studies 
have therefore focused on the intestinal and respiratory tracts, however there is growing 
evidence that the mucosal epithelium of the female reproductive tract is also an 
important site of TLR activity (Quayle 2002; Wira and Fahey 2004).
1.4 TLR EXPRESSION AND FUNCTION IN HUMAN REPRODUCTION
In recent years there has been much interest in the role of various cytokines in human 
reproduction. As TLRs have emerged vital to cytokine production, the existence of 
various TLRs and their intracellular pathways have begun to be explored in human 
reproductive tissues. Whilst the studies of TLRs in the male reproductive tract is still in 
its infancy (Robertson 2005), more progress regarding the female reproductive tract has 
been made.
1.4.1 The female reproductive tract
Tissues of the lower reproductive tract are populated by a rich commensal microflora, 
which limit the growth of more virulent microorganisms. The major commensals at this 
site include Lactobacillus, Gardnerella vaginalis and Escherichia coli. In addition, 
common pathogens that can populate the lower genital tract include Neisseria 
gonorrhoeae, Chlamydia trachomatis and Candida albicans (Larsen and Monif 2001; 
Quayle 2002). The mucus produced by the cervix provides somewhat of a barrier, 
however, this can be breached and the upper tract is, on occasion, exposed to both 
commensal bacteria and pathogenic microbes through either peristaltic contractions or 
intercourse (Profet 1993; Crane-Godreau and Wira 2004). Infection within the upper
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tract can have serious consequences, such as chronic pelvic inflammation, infertility and 
pregnancy complications (Witkin 2002). Therefore, such infectious agents must be 
quickly removed, whilst sustaining the resident microbial population of the lower tract. 
However, commensal and pathogenic microorganisms share PAMPs, and should thus 
have the same ability to trigger innate immune response pathways such as those 
mediated by TLRs. This creates the possibility of either hyper-responsiveness to resident 
microorganisms or the depletion of commensal populations. Yet mucosal systems, 
including the female reproductive tract, are colonized by commensal microflora, and 
these systems are not subject to constant inflammation under normal conditions. 
However, in the presence of a pathogen, a robust immune response can be generated and 
the infection is resolved. This then raises the question of how the mucosal immune 
system, such as that of the female reproductive tract, can distinguish between what is 
pathogenic and what is not.
TLRs are differentially expressed in the epithelia of different regions of the female 
reproductive tract and this has been postulated to prevent inappropriate reactivity to 
commensal populations. For example, TLR4 protein was detected 
immunhistochemically in the endocervix, endometrium and uterine tubes but not in the 
vagina and ectocervix (Fazeli, Bruce et al. 2005). TLR4 could thus play an important 
role in host defence against ascending infection. Similarly, endometrial epithelial cells 
were found to express TLRs 1-9 (Schaefer, Desouza et al. 2004).
Alternative hypotheses for maintenance of commensal flora and anti-pathogen activity 
have been forwarded (Strober 2004). Rather than avoiding a response towards 
commensals by minimal expression of TLRs at relevant sites, it has been suggested that 
these microbes may in fact be essential for protecting mucosal epithelia from direct 
tissue injury by inducing the production of cytoprotective factors such as TNFa, IL-6 
and heat shock proteins in response to commensal microbes (Hooper and Gordon 2001; 
Rakoff-Nahoum, Paglino et al. 2004). These findings shed new light on the function of 
TLRs in host defence and the role of commensal microorganisms in mucosal immunity,
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especially in the female reproductive tract. This in turn raises the question of whether 
TLRs also play a role in innate immune responses during pregnancy (Abrahams 2005a).
1,4.2 The function of Toll-like receptors in pregnancy
There is a wealth of literature supporting the production of cytokines by gestation- 
associated tissues in response to both intra-uterine infection or ex vivo stimulation with 
microbial products such as LPS. As TLRs have been found to link microbial ligands and 
the production of various inflammatory mediators, it has been postulated that TLRs 
provide a mechanism of cytokine production at the matemo-fetal interface.
1.4.2.1 Placenta
The placenta constitutes a physical and immunological barrier against invading 
infectious agents and has been called a pregnancy-specific component of the innate 
immune system (Holmlund, Cebers et al. 2002). Most TLR research in the context of 
pregnancy has focused on the placenta, although even these studies remain limited. 
Transcripts for TLRs 1-10 have been detected in the term human placenta (Zarember 
and Godowski 2002; Klaffenbach D 2005; Nishimura and Naito 2005; Mitsunari M
2006). Various cell types in the preterm and term placenta, including Hofbauer cells, 
villous, extravillous and intermediate trophoblasts, express TLR2 and TLR4 protein 
(Holmlund, Cebers et al. 2002; Kumazaki, Nakayama et al. 2004; Beijar EC 2006) as 
revealed by immunohistochemical studies. Holmlund et al demonstrated that term 
syncytiotrophoblast and intermediate trophoblast cells express TLR2 and TLR4 
(Holmlund, Cebers et al. 2002). In contrast, Kumazaki et al found the TLR4 positive 
placental cells to be term extravillous and intermediate trophoblasts. Such contradictory 
findings might result from the type of antibodies used or the methodology employed. 
Kim et al (Kim, Romero et al. 2004), using real-time quantitative reverse transcriptase 
polymerase chain reaction (q-PCR), found TLR2 and TLR4 mRNA levels to be 
significantly higher in chorioamnion from women at term with spontaneous labour than 
women not in labour. This is the only study to date suggesting that changes in TLR 
expression are associated with labour. However, these three studies do clearly indicate 
the expression of at least TLR2 and TLR4 by cells of the placenta. Similarly, in preterm
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placentae with chorioamnionitis the inflammatory cells infiltrating the placenta 
expressed TLR4, and TLR4 expression on the villous Hofbauer cells was increased in 
comparison to preterm placenta without chorioamnionitis as well as term placentae 
(Kumazaki, Nakayama et al. 2004). These results suggest an important role of the 
villous Hofbauer cells in the activation of innate immune system in response to 
infectious pathogens in preterm placentas.
Thus, cells of the placenta including trophoblasts could indeed interact with 
microorganisms and initiate an immune response, as was proposed by Gulieria and 
Pollard (Guleria and Pollard 2000). Functional activity of TLR2, TLR3 and TLR4 have 
been reported for first and third trimester trophoblast/placenta (Holmlund, Cebers et al. 
2002; Abrahams, Bole-Aldo et al. 2004; Abrahams VM 2005; Abrahams VM 2006). 
Explants of term placenta do respond to ligands for TLR2 and TLR4 (zymosan and LPS, 
respectively) by producing IL-6 and IL-8 into culture supernatants (Holmlund, Cebers 
et al. 2002). However, this is the only work published so far in which the functional 
activity of TLRs at the matemo-fetal interface has been considered. Moreover, definitive 
data that these responses occur via TLR 2 and/or 4 have not been provided yet.
Since an intrauterine infection might precede implantation, recent work has focused on 
the function of TLRs in the placenta during the first trimester of pregnancy. Shorter 
duration of pregnancies following in vitro fertilization treatment and repeated 
implantation failure is postulated to reflect infection and/or LPS contamination of the 
gestation-associated tissues as the consequence of the extensive invasive procedures 
involved in the treatment (Romero, Espinoza et al. 2004). Ligation of TLR4 by LPS 
triggers first trimester villous cytotrophoblasts and extravillous trophoblast cells to 
generate a classical inflammatory response, characterized by the increased production of 
both pro- and anti-inflammatory cytokines like IL-6, IL-8, TNF-a, IL-1, IL-10 and IL-4 
(Abrahams, 2004). In contrast, the ligation of TLR2 by PGN fails to upregulate cytokine 
production by trophoblast cells but instead induces apoptosis of first trimester 
trophoblast cells (Abrahams, Bole-Aldo et al. 2004). Elevated trophoblast apoptosis 
occurs in pregnancies complicated with IUGR, pre-eclampsia and in preterm births 
(Ishihara, Matsuo et al. 2002). These complications have also been associated with
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intrauterine infections (Romero, 2003). As mediators of both a proinflammatory 
response and apoptosis, TLRs expressed at the maternal-fetal interface could play an 
important role in the pathogenesis of all of these disorders. In this regard, a very recent 
study by Kim et al revealed significantly higher percentage of TLR4 positive interstitial 
trophoblasts on the placental bed biopsies from patients with preeclampsia (Kim, 
Romero et al. 2005).
Intrauterine infections during pregnancy could have either a direct or indirect effect 
upon trophoblast cell survival, depending upon which TLR is activated. A pathogen 
might directly promote trophoblast cell death through TLR2. Alternatively, triggering 
TLR4 would lead to production of high levels of cytokines, including TNFa and IFNy, 
which in turn could promote trophoblast cell apoptosis (Crocker, Barratt et al. 2001). 
Together, these studies suggest that trophoblast cells can indeed function similarly to 
cells of the innate immune system, by recognising and responding to components of 
microorganisms and in cases of chronic ligand exposure can promote tissue dysfunction 
leading to pregnancy complications.
1.4,2,2 Decidua
The decidua contains many cell types able to produce a variety of inflammatory 
mediators and with the potential to mount an immune response against a pathogen (Mor 
and VM 2002). TLR2 and TLR4 protein have been detected in infiltrating cells, most 
likely macrophages and neutrophils, during inflammation of term decidua (Kim, Romero 
et al. 2004). Term decidual stromal cells also express these innate immune receptors, 
suggesting these cells might also contribute to the resolution of an invasive infection 
(Canavan , Shaival et al. 2004). Cells from first trimester decidua also express TLR1, 2 
and 4 and studies to further characterise the expression and function of decidual TLRs 
are currently underway by this group (Abrahams and Mor. 2004). Recently TLRs have 
been studied in human laboured and non-laboured myometrium, and the authors found 
TLR expression to be upregulated with increasing gestation and not by onset of labour 
(R Youssef 2006).
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1.4.2.3 Amnion
Amniotic epithelial cells clearly possess the mechanisms necessary to specifically 
recognise and respond to bacteria. Both TLR2 and TLR4 protein is expressed by 
amniotic epithelial cells and TLR2 expression was significantly higher in patients with 
chorioamnionitis (Kim, Romero et al. 2004). Interestingly, TLR2 expression was 
confined to the basal surface of amniotic epithelial cells in cases without 
chorioamnionitis, but this polarisation was lost in the presence of inflammation. (Kim, 
Romero et al. 2004). This expression pattern is analogous to TLR5 expression in gut 
epithelium, supporting the hypothesis that a pathogen must breach certain barriers before 
a response can be mounted (Gewirtz, Navas et al. 2001). Interestingly in cases of 
inflammation, such as in chorioamnionitis, this polarised distribution of TLR2 is lost and 
both TLR2 and TLR4 expression is upregulated (Kim, Romero et al. 2004). Similar 
upregulation of TLR2 and 4 occurs in membranes from women with spontaneous labour 
at term compared to women who were not in labour (Kim, Romero et al. 2005).
1.4.2.4 Cervix
As discussed above the cervix undergoes dramatic remodelling during parturition with 
numerous inflammatory mediators implicated in this. To date, only one study has been 
published in which the gene expression of TLRs in the cervix after vaginal delivery or 
elective caesarean section was determined. The microarrays used in this analysis 
covered approximately 47,000 probe sets including ones for TLR2, TLR3, TLR4 and 
TLR5 and revealed a significant decrease in expression of transcripts for TLR3 and 
TLR5 that could be confirmed by conventional quantitative PCR (the apparent up­
regulation of TLR2 and TLR4 in the microarray study could not be confirmed) (Hassan, 
Romero et al. 2006; Hassan SS 2006). The biological significance of this remains to be 
determined but could reflect a direct role for TLR3 and TLR5 in labour via perhaps as 
yet unidentified endogenous ligands or down-regulation of these two receptors by any of 
the inflammatory mediators up-regulated in the cervix at this time.
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In conclusion, elucidation of biological functions of TLRs in placenta and other 
gestation-associated tissues under physiological conditions requires further 
investigation.
1.5 TLRs AND LABOUR
1.5.1 TLRs and Term labour
A comparison has been made between the cellular and autocoid events that occur at the
time of human labour and delivery and those that occur in association with inflammation
and infection (Liggins, Fairclough et al. 1973). This analogy is highlighted in cases of 
bacterial infection associated preterm labour (Romero, Gomez et al. 2001) and also in 
term labour (Elliott, Loudon et al. 2001). The process of labour involves three 
physiologically interdependent processes: remodelling of the cervix to allow it to stretch 
open to the width of the reproductive tract, weakening and rupture of the membranes in 
the region that overlies the cervix and the initiation of rhythmic contractions of 
increasing amplitude and frequency that ultimately forces the fetus and placenta from 
the uterus.
Some or most of these processes seem to be mediated by pro-inflammatory cytokines, 
suggesting that the immune privileges that the fetal-placental unit has enjoyed during 
pregnancy are revoked at the time of labour (Elliott, Allport et al. 2001; Peltier 2003). 
TLR signalling could have a role in initiating these responses (Figure 1.5). An 
inflammatory response during labour might also help to remove placental fragments and 
prepare the uterus for the pathogens that it will undoubtedly encounter during the 
immediate postpartum period.
So far we know that progesterone withdrawal plays a role in initiation of labour. In 
rodents and ruminants labour is preceded by a rapid decline in peripheral progesterone 
concentrations (Liggins, Fairclough et al. 1973). However, in primates and guinea pigs 
progesterone concentrations remain elevated until the delivery of the placenta. Recent 
studies have suggested that there may be a "functional withdrawal" of progesterone in 
primates by modulation of progesterone receptors and that this might be mediated via
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TLRs. In the decidua there is a significant loss in progesterone receptor binding to its
response element in samples collected after labour (Henderson and Wilson 2001). 
During labour, there is a significant shift of progesterone receptor types in the 
myometrium from the B-form to the A-foim and expression of both receptors on the 
amnion is significantly reduced (Haluska, Wells et al. 2002). The A-form of the 
progesterone receptor appears to inhibit signal transduction of the B-form because 
myometrial cells transfected with both receptors failed to initiate gene expression, 
whereas those transfected with the B-form only did (Pieber, Allport et al. 2001). In 
human cervical stroma, a shift from B-form to A-form of the progesterone receptor with 
no total change in progesterone receptors has also been described (Deng, P et al. 2003). 
The progesterone receptor is important in suppressing the inflammatory properties of 
estradiol in mice (Tibbetts, Conneely et al. 1999) and abrogating the function of 
progesterone receptors could permit proinflammatory cascades to occur in utero at term 
in conjunction with rising estradiol levels.
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Figure 1.5 Model for biochemical cascades involved in labour.
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With the influence of progesterone abrogated, IL-8, IL-lp, IL-6 and TNF-a production 
increases in the human cervix, perhaps via a TLR mediated pathway, during cervical 
ripening and labour. Proinflammatory cytokines can induce the ripening of the cervix in 
a number of ways. IL-ip and TNF-a increase the production of matrix metalloproteinase 
(MMP)-l, MMP-3, MMP-9, and cathepsins (Watari, Watari et al. 1999) and IL-ip 
down-regulates the expression of tissue inhibitor of metalloproteinase (TIMP)-2, an 
endogenous inhibitor of MMP-2. A shift in the balance towards proteinase activity 
favours digestion of collagen and elastin fibres in the extracellular matrix of the cervix 
to further increase cervical compliance. IL-lp can also act on a number of cell types to 
increase the production of cyclooxygenase (COX)-2 and thereby PGE2 , the most 
effective chemical for inducing cervical dilation in women. IL-la, which uses the same 
receptor as IL-lp, has been shown experimentally to increase COX-2 and PGE2 
production by rabbit cervical smooth muscle cells (Sato, Michizu et al. 2001). PGE2 may 
then further stimulate labour by increasing the production of proteinases or may play an 
indirect role by increasing the permeability of blood vessels for leukocyte trafficking 
(Kelly 2002). Nitric oxide (NO), another proinflammatory mediator that is increased at 
term, may also contribute to vasodilatation in order to facilitate leukocyte trafficking.
A similar proinflammatory process takes place in the membranes and the myometrium. 
During labour, the production of IL-8, TNF-a, IL-6 and IL-ip increases in the 
membranes (Young, Thomson et al. 2002) and these mediators increase the production 
of prostaglandins. Prostaglandins, in turn, stimulate myometrial contractility and 
cervical ripening. Increased levels of protein and/or mRNA for IL-ip, TNF-a and IL-6 
in the myometrium are also associated with labour (Young, Thomson et al. 2002) 
(Osman, Young et al. 2003). These pro-inflammatory cytokines have been 
immunolocalised to the leukocytes in the myometrium, numbers of which are increased 
during labour. IL-lp and TNF-a stimulate arachidonic acid release, activate 
phospholipid metabolism and increase the production of prostaglandins by the 
myometrium (Pollard, 1991). IL-lp activates a signal transduction system involving NF- 
kB to increase the expression of COX-2 (Belt, 1999), which is increased in the 
myometrium during labour (Slater, 1999), and stimulates the production of PGE2 by
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myometrial cells (Todd, 1996). These effects of IL-ip on myometrial cells are similar to 
the effects of oxytocin which also upregulates COX-2 and PGE2 production by 
myometrial cells. Oxytocin and PGE2 both increase the intracellular calcium 
concentration in myometrial cells, which is required for uterine contractions (Thornton, 
Gillespie et al. 1992).
Although IL-6 has no effect on prostaglandin production by myometrial cells (Todd, 
Dundoo et al. 1996) and is unable to stimulate myometrial contractions (Dajani, 1994), 
this cytokine might play a role in labour by increasing the expression of oxytocin 
receptors on myometrial cells (Rauk, Friebe-Hoffmann et al. 2001) thereby increasing 
their responsiveness to oxytocin. Like IL-ip, IL-6 can also increase oxytocin secretion 
by myometrial cells (Friebe-Hoffmann, Chiao et al. 2001). IL-lp and TNF-a can also 
increase the production of MMP-9 by myometrial cells, which may be important for 
detachment of the placenta (Roh, Oh et al. 2000).
Thus, undoubtedly, cytokine production increases several folds at the matemo-fetal 
interface at the onset (none of the cytokines or related molecules however can be 
measured at the onset of labour in humans) of labour whether at term or preterm. It is 
still not clear how this happens. However TLR-mediated signalling pathways leading to 
a defined cytokine output from the stimulated cell might be one of the mechanisms 
instrumental in this process.
1,5.2 Preterm labour
As discussed previously, bacterial infections, if present within the uterus during 
pregnancy, can represent a significant threat to the well being of the fetus. Indeed, 
animal models of pregnancy complications have been generated by the administration of 
Gram-negative bacterial LPS (Bennett, Terrone et al. 2000; Wang and Hirsch 2003). 
Since clinical studies have shown an association between intrauterine infections and 
preterm labour (Elovitz, Wang et al. 2003; Wang and Hirsch 2003), it can be 
hypothesised that certain cell types within gestation-associated tissues recognise and 
respond to bacterial components through TLRs. LPS from Gram-negative bacteria has
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been implicated in IA-PTL and there have been a number of studies exploring the role of 
TLR4 in preterm labour. Functional TLR4 has been implicated in heat killed E.coli 
mediated preterm labour in mice (Wang and Hirsch 2003). Thus, TLRs expressed at the 
maternal-fetal interface could play an important role in the pathogenesis of infection- 
associated prematurity (Abrahams 2005a). Besides the pathophysiological evidence, a 
role for TLRs in IA-PTL also comes from the genetic studies. A polymorphism 
(Asp299Gly) in TLR4 associated with impaired TLR4 function and an increased 
likelihood of Gram-negative sepsis was carried more often by preterm infants than term 
infants or by mothers delivering preterm than at term (Lorenz, Hallman et al. 2002). 
Unpublished data referred to by this same group highlight that studies should not be 
restricted to TLR4 as in the same Finnish population there was a trend towards higher 
frequency of TLR2 mutations in preterm compared with term infants.
Thus one can hypothesise that once present within the uterus; an infectious agent might 
take one of two, not mutually exclusive, main routes. Firstly, an infectious agent might 
cross the fetal membranes and if successful, proceed to infect the fetus. Alternatively, it 
might gain access to the maternal-fetal interface by infecting the placenta or maternal 
deciduas (Goncalves, Chaiworapongsa et al. 2002). As shown in Figure 1.4b TLRs 
recognise conserved motifs of microbial origin or that are indicative of cellular damage 
and mediate the production of various proinflammatory mediators that differ depending 
on the TLR(s) stimulated (Erroi, Fantuzzi et al. 1993; Deetz, Jagielo et al. 1997). These 
mediators (such as TNFa, IL-6, IL-8) interact to augment their own production, recruit 
neutrophils and macrophages to the maternal-fetal interface, and increase the production 
of downstream mediators of inflammation - the most important of which seem to be 
prostaglandins and matrix metalloproteinases. As discussed above for term labour 
(Figure 1.5) these effects include cervical ripening and dilatation and uterine 
contractions thereby activating the parturition mechanism prematurely (Ville 2001). 
During much of pregnancy, immunosuppressive substances such as progesterone and IL- 
10 control these proinflammatory cascades and the current literature suggests that 
excessive levels of stress proteins or infectious organisms override the protective effects 
of such molecules to cause preterm labor and/or PPROM (Peltier 2003).
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Recently it has been suggested that infection might trigger apoptosis and that 
disturbances in the regulation of apoptosis within the placenta might be associated with 
abnormal pregnancy outcomes (Jerzak and Bischof 2002). Elevated trophoblast 
apoptosis is seen during the first trimester of pregnancies complicated with IUGR or 
preeclampsia (Ishihara N, 2002; Smith SC et al, 1997) and in preterm births (Kakinuma, 
Kuwayama et al. 1997; Balkundi, Ziegler et al. 2003). It has been suggested that certain 
intrauterine infections during pregnancy have either a direct or indirect effect upon 
trophoblast cell survival, depending upon which TLR is activated (Abrahams VM, 
2004b).
The study of TLR mediated inflammation at the maternal-fetal interface is in its infancy. 
A better understanding of these proteins and the signal transduction cascades that they 
mediate might explain why some pregnancies are complicated by PTL and PPROM 
whereas others are only affected by PPROM. More investigations into the endogenous 
activators of the TLRs might also explain how PTL and PPROM can occur in the 
absence of infection (e.g. preeclampsia, multiple gestation, teenage pregnancy, or with 
excessive tobacco and alcohol consumption). These molecules might offer excellent 
targets for therapeutic strategies because they are upstream mediators of the 
proinflammatory cascade that ultimately results in PTL.
1.6 CLINICAL PERSPECTIVE
Despite the recognition over the past two decades that intrauterine infection and 
inflammation are causal factors for a significant number of preterm deliveries, attempts 
to reduce the number of preterm births using various antibiotic treatment regimes have 
proved ineffective. Again none of the tocolytic drugs known and used so far have been 
successful in stopping preterm labour (Sanchez-Ramos, Kaunitz et al. 1999) (Figure- 
1.6).
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Figure 1.6 Time-line fo r  investigations o f  causes and prevention o f  preterm labour.
Histological and in vitro studies suggest that the solution might be the rapid suppression 
of inflammatory reactions triggered by microbial products before the irreversible 
initiation and propagation of positive feed-forward cascades that precipitate preterm 
labour. The NF-kB transcription factor serves as a focal point for inflammatory 
mediators such as TNFa, LPS and the TLR family. A number o f pharmacological 
inhibitors of the NF-kB activation pathway have been evaluated, using gestational 
membrane explants and perfusion methodologies, in an attempt to determine if this 
might be a valuable approach for the treatment and prevention o f IA-PTL (Keelan 
2004). Four NF-kB inhibitors were initially evaluated across a range of doses: 
Sulfasalazine (SSZ), BAY-11-7085, Helanalin, and Pyrrolidine dithiocarbamate. SSZ 
treatment of LPS stimulated fetal membranes with attached decidua resulted in 
significantly reduced production of TNF-a in both the maternal and fetal compartments. 
Similarly, IL-6 levels after treatment were abrogated in the maternal compartment and 
significantly reduced in the fetal compartment.
These studies suggest that the NF-kB inhibitor SSZ is capable o f suppressing LPS- 
stimulated pro-inflammatory cytokine production in gestational membranes with a rapid 
onset o f action (2 hours or less) and at least 20 hours duration. The administration of
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SSZ does not appear to be associated with onset of cell death, arguing against the 
possibility that NF-kB inhibition might be pro-apoptotic in these tissues. These data 
support the further evaluation of SSZ, a drug used in the treatment of inflammatory 
bowel disease and rheumatoid arthritis, as a treatment modality for the prevention of LA- 
PTL.
The identification of TLRs as upstream mediators of inflammation offers alternative 
therapeutic targets for preventing common pregnancy complications such as preterm 
labour, and hopefully others such as IUGR and preeclampsia. Alternatively, these 
receptors might serve as clinical biomarkers of disease. There are at least three strategies 
for interfering with TLR signalling (Opal and Huber 2002), with the specific goal of 
reducing the consequences of their biological effects.
1. The generation of specific soluble TLRs to bind and neutralise their respective 
microbial ligands. Recently, soluble TLR2 was identified in human plasma and breast 
milk and found to be produced by peripheral blood monocytes (LeBouder, Rey-Nores et 
al. 2003). Soluble TLRs might function by modulating specific TLR mediated responses 
or alternatively, might bind to microorganisms and flag them for destruction by the 
complement system or by phagocytosis (Medzhitov and Janeway 2002). Soluble TLRs 
might, therefore, provide new markers of pregnancy complications as well as a potential 
target for therapeutic interventions.
2. The development of small antagonistic molecules or antibodies that interfere with the 
extracellular domain of TLRs and act as TLR antagonists.
3. The generation of small molecules that interfere with the intracellular domain of 
TLRs and prevent the interaction with distal intracellular signalling molecules (e.g., 
MyD8 8 , IKK) (Ulevitch 2004).
1-42
A possible fourth strategy is the use of an inhibitor of NF-kB, like sulfasalazine, as 
suggested by Keelan et al, 2004.
Similarly a genetic approach might provide important information regarding an 
individual’s susceptibility to developing infection-based fertility problems or pregnancy 
complications. Polymorphisms in TLR2 and 4 have been identified and have been linked 
with altered responsiveness to TLR ligands and these genetic mutations might have an 
impact clinically (Lorenz, Hallman et al. 2002; von Aulock, Schroder et al. 2004).
It is very much possible that therapeutic use of any of the above could neutralise 
beneficial components of the host defence. However, if the genetic basis of 
susceptibility to infection can be determined, tools will become available that might help 
identify patients at high risk for pregnancy complications like preterm labour and 
appropriate interventions could then be individually tailored (pharmacogenetics).
1.7 HYPOTHESIS
The contribution of TLRs to inflammation at the matemo-fetal interface is only 
beginning to be understood. It is clear that a better understanding of TLRs and their 
signalling cascades is of relevance to labour, be it at term or preterm, as the downstream 
effects of activating any particular TLR will be similar irrespective of whether an 
endogenous or exogenous ligand is the stimulus. Spontaneous term labour and infection- 
associated preterm labour can therefore feasibly be mediated by the same TLR-mediated 
pathways leading to the common outcome of elevated pro-inflammatory cytokine 
production and the effects on gestation-associated tissues for the initiation and 
maintenance of labour.
Therefore the hypothesis to be tested is: “that activation o f toll-like receptors by 
endogenous and exogenous ligands contributes to term and preterm labour, 
respectively”
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1.8 OBJECTIVES
1. To determine TLR expression and activity in the term human placenta: Placentas will 
be collected after delivery at term in the absence of labour. Explants of placental 
tissue will be cultured in vitro in the presence of optimised concentrations of various 
TLR ligands (for TLR 1-9) and pro- and anti-inflammatory cytokine production 
(TNFa, IL-6 , IL- 8  & IL-10) into the culture supernatants will be measured using 
ELISA. Expression of each TLR will be further investigated using RT-PCR and q- 
PCR for mRNA analysis.
2. To investigate changes in TLR response and expression in term labour: The 
methodologies used in ( 1 ) above will be applied to placentas collected after the 
completion of spontaneous labour at term.
3. To determine TLR expression and response in preterm labour: As in (1) above 
biopsies will be taken from placentas delivered after preterm labour for explant 
culture, mRNA analysis and quantification of TLR expression by RT-PCR and q- 
PCR.
1.9 OUTCOMES:
The proposed outcomes are:
(i) Basal expression and activity of TLR 1-9 in the human term placenta.
(ii) Ontogeny of TLR 1-9 expression and/or activity in the human placenta.
(iii) Changes in TLR expression and/or activity in spontaneous term labour.
(iv) TLR 1-9 expression and/or activity in infection-associated preterm labour 
compared with term labour.
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CHAPTER 2 
MATERIALS AND METHODS
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2.1 PATIENT RECRUITMENT AND SAMPLES
All participants gave informed written consent to have the placenta collected after 
delivery. Approval for the study was given by the Local Research Ethics Committee 
covering Bridgend, Neath Port Talbot and Swansea (LREC Project Registration No: 
04/WMW02/18). Relevant documentation (Consent form) is shown in Appendix 1.
2,1.1 Patient Groups
Otherwise healthy pregnant women with a singleton fetus were recruited to give the 
following three groups (Appendix 2):
1. Term non-laboured group (gestational age >37 weeks): Women booked for 
elective caesarean section at term due to varied obstetric reasons such as 
cephalopelvic disproportion, breech presentation and/or previous caesarean 
section were approached when attending the antenatal day assessment unit at 
Singleton Hospital, Swansea for a pre-operative assessment. The placenta was 
collected at the time of the caesarean section by liaising with the delivery suite 
team.
2. Term laboured group (gestational age >37 weeks): Women were approached in 
the delivery suite either during early labour or soon after a spontaneous vaginal 
delivery as deemed suitable by the midwife responsible for the case.
3. Preterm group (gestational age >24 weeks to <37 weeks): Women were 
approached either at their admission in early labour or soon after delivery again 
in full liaison with the midwives. Whilst the primary aim was to include preterm 
deliveries with infectious etiology, ‘all cases’ were accepted.
Exclusion criteria: Women with autoimmune or other immunological disorders were 
excluded from the study as were the women with diabetes mellitus including gestational 
diabetes and multiple pregnancies and any other medical infections and illnesses.
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Demographic and obstetric details'. Gestational age was calculated either by an early 
ultrasound or by the first day of the last menstrual period (when women were sure of 
their dates). The necessary demographic and obstetric details were obtained from the 
hospital notes of both mother and baby and were recorded on a set proforma (Appendix 
3). The mothers were aged 17-37 years old (median 28.5 years) and had up to 5 previous 
children. The term babies (18 boys, 16 girls) weighed 2610-4760 grams (median 3685 
grams). The preterm babies (9 boys, 6  girls) weighed 860-3230 grams (median 2045 
grams). The weight of the term placentae ranged from 438-831 grams (median 634.5 
grams) and the preterm placentae ranged from 271-835 grams (median 553.0 grams). 
The details are shown in Table 2.1.
Variables Non-Laboured
(ECS)
Laboured (SVD) Preterm
(25-36 weeks)
Maternal age 
(years)
20 - 36 (median 
30.5) p=0.002
17 - 35(median 26) 15-37 (median 
26) p=0.949
Parity 1 - 3  (median 1) 
p=0.887
1 - 5  (median 1) 1 - 2  (median 1 ) 
p=0.119
Placental weight 
(grams)
438 - 818 (median 
683) p=0.964
478 - 831 (median 
648)
271 - 515 
(median 309)
Sex 7 boys; 10 girls 
p=0.506
10 boys; 7 girls 9 boys; 6  girls 
p=0.908
Birth weight 
(grams)
2610 -  4450 (median 
3550). p=0.977
2950 - 4760 (median 
3440).
860-3260
(median
2175).
Table 2.1 Demographic and obstetric details o f the two experimental groups, p  values in column two are 
between the term nonlaboured and term laboured while p  values in column four are between term svd and 
preterm groups.
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2.1.2 Sample Size
Power calculation analysis was based on previous studies by the group in which 
placental cytokine production was the primary outcome and was performed using PS- 
Power and Sample Size Calculation software (Version 2.1.31). This analysis revealed 
that 17 placentae were required per group for the comparison of labour versus non­
labour at term. Due to time limitations as many preterm samples as possible were 
collected (n = 15 at varying gestational ages).
2.1.3 Collection of Samples
Immediately following delivery, placentae were collected into a clean bag and placed in 
a clean bucket and taken to the laboratory for processing.
2.2 PROCESSING OF PLACENTA
2.2.1 Placental Explant Culture
Care was taken in handling the placenta to limit contamination. The placenta was 
weighed and then transferred to a Class II tissue culture cabinet wherein all procedures 
were performed. Placental explant cultures (0.2 g of wet tissue/ml) were prepared as 
described (Hanna, Hanna et al. 2000). The overlaying decidua basalis on the maternal 
side of the placenta was removed and 1 cm3 pieces of placental tissue were taken from 
different sites across the placenta and placed into sterile phosphate buffered saline (PBS; 
Invitrogen, UK). Disturbance of the chorioamnion was avoided. Pieces of tissue were 
washed repeatedly with PBS to remove contaminating blood. The tissue was then 
minced into smaller pieces (approximately 1-2 mm3) and washed further with PBS. 
Pieces of placental tissue (0.5g) were transferred into each well of a standard tissue 
culture 6 -well plate (Grenier Bio-one, Germany) containing 2.5mls of Ultraculture 
medium (Cambrex, Belgium) supplemented with 2mM Glutamax (Invitrogen) and 
lOOU/ml penicillin G, 100pg/ml streptomycin sulphate and 0.25pg/ml amphotericin B 
(PSF; Invtirogen). Care was taken to avoid any blood clots or fibrous tissue.
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Once the explant cultures were prepared, different stimuli were added to each well as 
shown in Table 2.2 (details in Chapter 3). An unstimulated control was always included. 
Immediately after adding ligands, the plates were incubated at 37°C in 5% CO2 for 24 
hours. All stimuli were purchased from InvivoGen, SanDiego, CA, USA. Cell/tissue free 
culture supernatants were collected by centrifugation and stored at -20°C until assayed.
Maintenance of LPS-free conditions
Extreme care was taken to limit LPS/endotoxin contamination during explant 
preparation. These precautions included the use of disposable plastic-ware and other 
consumables (e.g. scissors) whenever possible (Jones, Finlay-Jones et al. 1997). All 
media/reagents were tested by the manufacturers and found to be endotoxin free.
2.2.2 Biopsies for RNA analysis
Additional placental tissue was removed and washed several times in cold PBS to 
remove contaminating blood. A fixed amount of the tissue (0.2-0.26g) was transferred 
into 1.3ml of RNA later® (Sigma, USA). Biopsies in KNAlater® were stored in the fridge 
for 48 hours before storing at -80°C until analysis.
2.3 TREATMENT OF PLACENTAL EXPLANTS
2.3.1 TLR Ligands
The placental explants from each donor were treated with each of the ligands as shown 
in the Table 2.2. Response curves for each ligand were conducted to determine optimal 
concentration to use.
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TLR Ligands TLR stimulated
Peptidoglycan (S. aureus) TLR2
Polyinosine-polycytidilic acid (Poly (I:C))- ds 
RNA
TLR3
Ultra Pure E.coli (0111 :B4) LPS TLR4
Flagellin (S. typhimurium) TLR5
Zymosan TLR2/6
R848 (anti viral synthetic compound) TLR7/8
Loxoribine TLR7/8
ssPoly-single stranded polyU oligonucleotide TLR7/8
CpG - unmethylated deoxycytidine- 
deoxyguanosine dinucleotide
TLR9
ODNC-control oligonucleotide 2216 Control
(for CpG TLR9)
Table 2.2 TLR ligands added to placental explant cultures.
2.3.2 Dexamethsone
Placental explants from term non-laboured placentas were treated with the optimised 
concentration of each TLR ligand in the presence of 0.4, 4 or 40 ng/ml dexamethasone 
(Sigma, USA) for 20 - 24 hours. Supernatants were harvested and stored at -20°C until 
analysis of IL- 6  levels by ELISA.
2.3.3 Pretreatment with Ligands
Placental explants from term non-laboured placentas were treated with the optimised 
concentration of each TLR ligand. After incubation at 37 °C for 20-24 hours, the tissue 
was washed by centrifugation and recultured in fresh media containing concentrations of 
TLR ligands as indicated in the results (Chapter 5). Supernatants were harvested after 
further 20 - 24 hours incubation and stored at -20 °C until analysis of IL- 6  levels by 
ELISA.
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2.4 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)
Cytokine concentrations in supernatants from placental explant cultures were determined 
using commercial ELISA kits according to the manufacturers’ instructions. The different 
cytokines measured and their sensitivities as specified by the manufacturers are shown 
in Table 2.3.
Cytokine Sensitivity Company
TNFa 4pg/ml OptEIA ELISA 
BD Biosciences, USA
IL-10 4pg/ml OptEIA ELISA
IL- 6 lpg/ml OptEIA ELISA
IL- 8 l-3pg/ml Pelkine ELISA Sanquin 
Reagents, The Netherlands.
IFN-a 8 pg/ml Module Set ELISA Med 
Systems Diagnostics, 
Austria.
IFN-y 2 pg/ml OptEIA ELISA
Table 2. 3 Details o f ELISA usedfor this study.
The methodology for all assays was essentially the same. Briefly, half area 96 well 
plates (Costar, Coming, USA) were coated with 50pl of capture antibody prepared in
0.05M carbonate/bicarbonate buffer pH 9.6 (prepared from carbonate-bicarbonate buffer 
capsules; Sigma, USA) or PBS as appropriate and incubated overnight in the fridge. 
After discarding excess coating antibody, nonspecific reactivity was blocked by 
incubation for 1 hour at room temperature with 1% bovine semm albumin (BSA; Sigma) 
in PBS (150pl/well). The plates were then washed three times with wash buffer (1% 
BSA in PBS with 0.05% Tween-20 (Sigma, USA); 200|il/well) before the sample or 
standard was applied in duplicates (50pl/well). After 2 hr incubation at room 
temperature, the plates were washed four times with the wash buffer as before and then,
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for OptEIA assays 50pl/well of biotinylated detecting antibody and avidin-horseradish 
peroxidase mix was added. For non-OptEIA assays, the biotinylated detecting antibody 
and avidin-horseradish peroxidase (both 50pl/well) were added separately and required, 
respectively, 1 or 2hrs and 30 or 60 minute incubation at room temperature (time of 
incubation was assay dependent). Plates were washed four times between detecting 
antibody as the next step. Upon completion of the incubation with avidin-horseradish 
peroxidase the contents of the wells were discarded and the plate was washed six times 
with wash buffer as before. Substrate chromogen (tetramethylbenzidine, BD 
Biosciences; 50pl/well; prepared according the manufacturer’s instructions) was then 
added and the blue colour allowed to develop (variable times for each cytokine assay). 
The reaction was stopped with 1M H2 SO4 and the subsequent colour intensity was 
recorded as the optical density at 450nm using an ELISA plate reader (Multiskan 
Ascent, model no. 354, Thermo Lab systems).
Cytokine concentrations in the samples were calculated in pg/ml from the standard curve 
(EXCEL; Microsoft office 2003).
2.5 GENE EXPRESSION
2.5.1 RNA Extraction
RNA was extracted using a modified method based on Reno et al (1997) known as the 
‘TRIspin method’. This method involves a homogenisation step with TRIzol™ 
(Invitrogen) followed by purification using the RNeasy® Mini Kit (Qiagen, UK).
Approximately 50mg of placental tissue was removed from the KNAlater® and 
homogenised in a FastPrep FP120A (Biol01 Savant, Qbiogene; The Netherlands) using 
2ml Lysing Matrix D tubes (Biol01 Systems; Qbiogene) containing 600pl TRIzol™. 
The homogenised sample was centrifuged at 20,000rpm for 5 minutes at 4°C. The 
supernatant was removed and incubated for 5 minutes at room temperature to allow for 
complete dissociation of nucleoprotein complexes. Chloroform (150pl) was then added 
to the supernatant and the sample mixed by repeated inversion prior to centrifugation at
2-8
20000 jc g for 15 minutes at 4°C. The upper aqueous phase was removed, and one 
volume of 70% ethanol was added to the aqueous phase and mixed well. This was 
transferred to a Qiagen assay minicolumn and RNA was isolated according to the 
manufacturer’s protocol. This kit isolates all RNA molecules longer than 200 
nucleotides, while low molecular weight RNAs, including 5S rRNA and tRNAs, are 
excluded. A total of 60pl RNA extract was obtained from each sample.
Any contaminating genomic DNA in the RNA extract was removed using the DNA-free 
DNase Kit (Ambion, UK) according to the manufacturer’s instructions. The yield of 
DNA free RNA was then quantified spectrophotometrically using NanoDrop (ND-3300 
flurospectrometer, NanoDrop Technologies; USA) and optical density ratios 
(OD260/OD280) were determined. A ratio > 1.7 was taken as satisfactory. RNA quality 
was also checked using the Agilent system (RNA 6000 Nano LabChip run on Agilent 
2100 Bioanalyzer).
2.5.2 Complementary DNA (cDNA) Synthesis (reverse transcription)
Reverse transcription was completed using Ambion’s RETROscript kit following the 
manufacturer's instructions. RNA (lpg) was reversed transcribed into cDNA using 
murine leukaemia virus reverse transcriptase enzyme and random decamers in a 20pl 
volume. To ensure that all of the reagents used for reverse transcription were DNA free, 
a no template control (NTC) which contained all of the reagents used for the reverse 
transcription and water in place of RNA was always included. To confirm that the 
reverse transcription worked a positive control (mouse liver RNA) provided in the kit 
was always included. The reaction mixture was incubated in a Polymearse Chain 
Reaction (PCR) thermal cycler (Flexigene; Techne, Cambridge, UK) at 44°C for 60 
minutes, and then heated to 92°C for 10 minutes to inactivate the enzyme.
To confirm that cDNA was synthesised a PCR amplifying the human S15 (ribosomal 
protein) gene was performed using l.Opl of the cDNA mixture (the rest was aliquoted 
for storage at -80°C). For each PCR, the following samples were included: (1) cDNA 
obtained from the experimental samples; (2) the corresponding RNA from each sample
2-9
to test for genomic DNA within the extracts; (3) a negative control which had all the 
PCR reagents but water in place of cDNA; (4) a NTC brought forward from the reverse 
transcription step; (5) a positive control which had cDNA from the mouse liver RNA as 
described above.
The inclusion of the controls assured the reliability of the PCR and the reverse 
transcription reactions. A total volume of 20pl containing cDNA, primers, dNTP, 
lOxPCR buffer from the kit along with thermostable Taq DNA polymerase (5U/pl, 
ABgene, UK) and nuclease free water was prepared for each sample according to the 
manufacturer's instructions and was placed in the thermal cycler. The primer sequences 
and cycling parameters are shown in Table 2.4.
Primer sequences- forward 5'- TTCCGCAAGTTCACCTACC
Primer sequences- reverse 5'- CGGGCCGGCCATGCTTTACG
Fragment length 361 bp
PCR conditions 94°C for 1 minute, 30 cycles of (94°C for 
30 seconds; 59°C for 30 seconds; 72°C 
for 30 seconds), 72°C for 4 minutes
Table 2.4 Primer sequences and cycling specifications fo r  the SI5 PCR used to confirm that cDNA 
synthesis was successful.
PCR products were analysed by electrophoresis through 1% agarose gel in IX Tris- 
borate-EDTA (TBE; Sigma-Aldrich, St. Louis, USA) containing ethidium bromide 
(18pl/100ml of agarose; Fluka, Biochemica, Sigma) at 100 volts for at least 30 minutes 
and subsequently visualised using UV light. If all stages of RNA extraction and cDNA 
synthesis were successful, bands of the appropriate size should be visible for all of the 
experimental samples and for the positive control but not for the RNA from the 
corresponding sample, NTC or the negative control. If bands were visible for the RNA 
extracts from the experimental samples, thereby indicating the presence of genomic 
DNA, these extracts were discarded, and fresh extracts prepared from the tissue stocks. 
Only upon ensuring that, after SI5 PCR, there were no bands visible from the fresh
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RNA extracts but that there were bands visible from the new cDNA samples was the 
cDNA used for real time quantitative PCR.
2.5.3 Real Time Quantitative PCR (qPCR)
Quantitative PCR was carried out using an iCycler PCR machine (iCyler IQ version 3.1, 
Bio-Rad, UK) for all of the genes of interest (TLR 1-10) and three house keeping genes; 
succinate dehydrogenase complex, subunit A (SDHA); TATA box binding protein 
(IBP); tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta 
polypeptide (YWHAZ), (Meller, Vadachkoria et al. 2005). The primers and PCR 
conditions used are listed in Table 2.5. All of the primers used have been published 
previously [(Vandesompele, De Preter et al. 2002; Zarember and Godowski 2002); 
http://medgen.ugent.be/rtprimerdb,primer ID2629)] and were synthesised by MWG 
Biotech AG (Ebersberg, Germany). The housekeeping genes were chosen based on a 
study that demonstrated that these three genes are the most stably expressed house 
keeping genes in the human placenta (Meller, Vadachkoria et al. 2005). This ensures 
that the gene expression profile comparisons have more sensitivity and stability.
Broadly for each qPCR, lpl of the cDNA (prepared as in section 2.5.2) was added to a 
20pl mix containing lpl each of appropriate forward and reverse primers (5pM), 7jnl IQ 
SYBR-green supermix (Bio-Rad, UK) and lOpl nuclease free water. Optimisation was 
performed for each qPCR for primer concentration, annealing temperature and, if 
required, magnesium chloride concentration (Table2.5). Apart from TLR7 (15pM of 
reverse primer) and TLR9 (3.5mM of magnesium chloride), all of the qPCRs had the 
same proportions of different components in the PCR mix.
The qPCR conditions for all PCRs only differed for the annealing temperatures. Each 
plate was treated at 95°C for 210 seconds and then 40 cycles of: 95°C for 30 seconds, 
appropriate annealing temperature for 30 seconds and 72°C for 10 seconds. The 
programme (iCyler IQ version 3.1) also enabled a melt curve for each qPCR to be 
undertaken to assist in the identification of any non-specific PCR products: the PCR 
product was heated at 95°C for 60 seconds, then 55°C for 60 seconds and then the
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temperature was increased by 0.5°C for 10 seconds each time for a total of 80 cycles. A 
single peak at the correct melting temperature indicated a reliable and desired PCR 
product.
As all samples and controls were to be analysed in triplicate, the total number of wells 
required meant that each qPCR had to be run over two plates. To ensure that the results 
were comparable, samples from the experimental groups were spread equally over both 
plates. The RNA extractions were performed in three batches as well, and care was 
taken to ensure that samples from each batch also were spread equally over both plates. 
Furthermore, to address plate to plate variation four ‘calibrator samples’: placental 
cDNA (lOOOng/ml and 300ng/ml) and spleen cDNA (lOOOng/ml and 300ng/ml) were 
included. These were run on both plates (Appendix 4). Therefore, in summary, the 
samples included on each plate were: (1) cDNA obtained from the experimental 
samples; (2) a no template control (NTC) brought forward from the reverse transcription 
step; (3) a negative control containing all PCR reagents but water in place of cDNA; (4) 
the four calibrator samples as detailed above. (See Appendix 5 for generalised layouts of 
Plates 1 and 2 for all qPCRs.)
PCR efficiency:
The efficiency of each PCR was determined for all TLR genes and the three house 
keeping genes. This was performed by generating two sets of standards using six 
different concentrations of RNA from two separate sources:
1. Placental tissue (elective caesarean section; RNA extracted using same protocol as 
outlined in section 2.5.1) - 3000ng/ml, lOOOng/ml, 300ng/ml, lOOng/ml, 30ng/ml and 
lOng/ml.
2. Spleen RNA (commercially produced RNA from Clontech, CA; USA) - 3000ng/ml, 
lOOOng/ml, 300ng/ml, lOOng/ml, 30ng/ml and lOng/ml.
These sets of standards were derived as follows: RNA concentration was determined 
using the Nanodrop (as described previously) and dilutions made with nuclease-free 
water to give the six concentrations required. These were individually reverse
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transcribed and the success of cDNA synthesis checked by SI5 PCR (all as described 
above). The resulting cDNA were run in triplicates on the iCycler along with the NTC 
and negative controls as before. Efficiencies were derived from both sources from three 
or four independent PCR runs.
Threshold cycle (Ct) values were obtained for each replicate of each standard and a 
standard curve (logarithm of the RNA concentration plotted against Ct) was drawn using 
the iCycler software. The standard curve was accepted if the R-squared value was > 
0.985. PCR efficiency was derived from the slope of the line, expressed as follows: 
Efficiency = 10(1/!lO|’e)- l  
Standard curves for all TLRs were run four times and the average of the three best 
efficiencies considered. Similarly standard curves for the three house keeping genes 
were run three times and the resulting average was taken for final calculation. These are 
presented in Table 2.6.
GENE EFFICIENCY- 
PLACENTAL TISSUE
EFFICIENCY- 
SPLEEN TISSUE
TLR1 1.89 2.07
TLR2 1.92 2.14
TLR3 1.94 2.08
TLR4 1.85 2.03
TLR5 1.91 2.02
TLR6 1.89 2.11
TLR7 1.91 2.02
TLR8 1.83 1.93
TLR9 1.99 2.16
TLR10 1.91 2.00
SDHA 1.92 2.06
TBP 1.82 1.91
YWHAZ 1.86 2.00
Table 2.6 PCR efficiency for experimental and house-keeping genes from placental and spleen RNA.
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Ideally the efficiency of a PCR reaction should be 2. As shown in Table 2.6 values for 
the placenta were less than 2. The efficiencies for spleen were higher than those of 
placenta but this is not unexpected as the spleen RNA is a commercially produced 
product, and probably much purer than the placental samples prepared specifically for 
this study. Therefore, for all subsequent analyses the efficiency results obtained from the 
placental tissue were used for calculating the expression of genes of interest and 
housekeeping genes as this was deemed more appropriate. Spleen was included as it 
provided a positive control as it is known to express TLRs 1- 10 (Zarember and 
Godowski 2002).
Analysis o f data:
Data were obtained using iCycler software and Ct values obtained from all samples were 
imported into qbase (version: 1.2.2). This software (http://medgen.ugent.be/qbase/) 
enabled a normalisation factor allowing for plate-to-plate variation/efficiencies of all 
genes but especially the three house keeping genes to be incorporated into any 
calculations. Thereby relative gene expression of the genes of interest could be 
calculated (Vandesompele, De Preter et al. 2002). All results were normalised against 
the lOOOng/ml placental sample.
2.6 STATISTICAL ANALYSIS
(i) Cytokine responses by non-laboured tissue to TLR ligands:
2-tailed Student’s t-test assuming samples to have unequal variance was 
applied. The statistical analysis was done using SPSS version 13 (SPSS Inc 
Chicago, USA). The differences were considered to be statistically 
significant when the p  value was < 0.05.
(ii) Cytokine responses by laboured versus non-laboured placental explants: 
Statistical comparison was made between the activities of each TLR in the 
two groups. As the data were not normally distributed the logarithmic values
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of the raw data were employed in the t-test for 2 independent samples. The 
statistical analysis was done using SPSS version 13. The differences were 
considered to be statistically significant when the p  value was < 0.05.
(iii) Gene expression analysis between laboured versus non-laboured placental 
explants: The comparison was made between the expression of each TLR in 
the two groups using the Mann Whitney U test for two independent samples 
The statistical analysis was done using SPSS version 13. The differences 
were considered to be statistically significant when thep  value was <0.05.
(iv) Cytokine responses by preterm laboured versus term laboured placental 
explants: Statistical comparison was made between the activities of each 
TLR in the 2 groups using the Mann Whitney U test for two independent 
samples. The statistical analysis was done using SPSS version 13. The 
differences were considered to be statistically significant when the p  value 
was < 0.05.
(v) Gene expression analysis between preterm laboured versus term laboured 
placental explants: The comparison between the expression of each TLR in 
the 2 groups was made using the Mann Whitney U test for two independent 
samples The statistical analysis was done using SPSS version 13. The 
differences were considered to be statistically significant when the p  value 
was < 0.05.
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CHAPTER 3
BASAL EXPRESSION AND ACTIVITY OF 
TLRs IN THE TERM HUMAN PLACENTA
3.1 INTRODUCTION
The placenta has many roles during pregnancy including being a physical and 
immunological barrier against invading infectious agents and, consequently, has been 
called a pregnancy-specific component of the innate immune system. The trophoblast in 
particular is postulated to play an important role in innate immune function (Holmlund, 
Cebers et al. 2002). As discussed in Chapter 7, TLRs have been identified as a family of 
pathogen recognition receptors with a central role in innate immunity. There is much 
interest in the contribution of TLRs to immunological functions at many tissue sites 
including those at the matemo-fetal interface. Although most pregnancy related TLR 
research has focused on the placenta, currently there are only few such studies.
Gene expression studies using human tissue cDNA libraries revealed that the placenta 
expressed transcripts for TLRs 1-10 (Zarember and Godowski 2002; Klaffenbach D 
2005; Nishimura and Naito 2005) with TLR3, TLR5, TLR7 and TLR8 being the most 
abundant. Detailed studies of TLR protein expression and function are more limited and 
generally focus on TLR2 and TLR4. Various cell types in the preterm and term placenta, 
including Hofbauer cells and villous, extravillous and intermediate trophoblasts, express 
TLR2 and TLR4 protein (Holmlund, Cebers et al. 2002; Kumazaki, Nakayama et al. 
2004; Beijar EC 2006) with preferential expression of TLR4 on the trophoblast plasma 
membrane facing the maternal circulation. Similarly, choriocarcinoma cell lines are 
positive by flow cytometry for cell surface TLR2 and TLR4, and intracellular TLR9 
(Klaffenbach D 2005).
Functional activity of TLR2, TLR3 and TLR4 have been reported for first and third 
trimester trophoblast/placenta (Holmlund, Cebers et al. 2002; Abrahams, Bole-Aldo et 
al. 2004; Abrahams VM 2005; Abrahams VM 2006); and choriocarcinoma cell lines are 
responsive to TLR2, TLR3, TLR4 and TLR9 agonists (Klaffenbach D 2005). Holmlund 
et al (2002) found that stimulation of term placental explants with either zymosan (a 
TLR2 ligand) or LPS (a TLR4 ligand) induced IL-6 and IL-8 cytokine production into 
culture supernatants.
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The functionality of TLRs other than TLR2, 3 and 4 within the human placenta and/or 
primary trophoblast remains unknown. Therefore, we undertook an investigation of the 
expression and activity of TLRs 1 - 10 in the term human placenta in the absence of 
labour and following completion of spontaneous onset term labour (chapter 4) to 
explore whether TLRs expressed in the term human placenta are functional, and whether 
changes in the expression and activity of these receptors is associated with spontaneous 
term labour (<chapter 4).
The primary objectives of the work presented in this chapter were:
(i) To evaluate the functional activity of TLRs 1-9 in the human term placenta (as 
no ligand for TLR 10 was identified at the time of the study, only TLRs 1-9 were 
studied).
(ii) To confirm the presence of transcripts for each TLR.
3.2 APPROACH
Placental explants from the ‘term non-laboured group’ were stimulated with TLR 
specific ligands. Cytokine output in response to stimulation was then an index of the 
capacity of the placenta to signal its response to that pathogen via a specific TLR. 
Several different cytokines, namely TNF-a, IL-6, IL-8 and IL-10, were measured using 
ELISA. Initial experiments determined the optimum concentration for each TLR ligand. 
On identifying optimal doses for each ligand, a further series of term non-laboured 
placental explant cultures (n=17) were exposed to TLR ligands and cytokine production 
determined. The expression of TLRs in the term non-laboured human placenta was also 
determined by polymerase chain reaction (n=12).
Statistical comparison was done by applying two-tailed student’s t-test assuming 
samples to have unequal variance using SPSS Version 13 (SPSS Inc Chicago, USA). 
The differences were considered to be statistically significant when p value was < 0.05.
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3.3 RESULTS
3.3.1 Dose response curves for each TLR ligand
Dose response curves based on published information and laboratory experience with 
stimulating peripheral blood mononuclear cells via TLR were conducted for all ligands 
of interest. These results (Figure 3.1a-f; n=3) were used to determine optimum 
concentration for use in all subsequent experiments (Table 3.1).
TLR Ligand TLR
stimulated
Treatment
Dose
Peptidoglycan (S. aureus) TLR2 3pg/ml
Zymosan TLR2/6 3pg/ml
Polyinosine-polycytidilic acid (Poly (I:C))- dsRNA TLR3 25pg/ml
Ultra Pure E.coli (0111 :B4) LPS TLR4 100 ng/ml
Flagellin (S. typhimurium) TLR5 lOOng/ml
R848 (anti viral synthetic compound) TLR7/8 1OOng/ml
Loxoribine TLR7/8 lOOpM
ssPoly - single-stranded polyU oligonucleotide TLR7/8 1 pg/ml
CpG - unmethylated deoxycytidine- 
deoxyguanosine dinucleotide
TLR9 lpM
ODNC-control oligonucleotide 2216 Control lpM
Table 3.1 The treatment doses used in the experimental work.
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Figure 3.1 Dose response curves fo r  different TLR ligands. Explants o f  non-laboured placentas (n=3) 
were cultured fo r  24 hours with doses o f  a) PGN, a TLR2 ligand; b) Poly I:C, a TLR3 ligand; c) LPS, a 
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3.3.2 Response of Placental explants to various TLR ligands
Placental explants from term non-laboured placentas (n=17) were stimulated with 
optimal doses of ligands and production of TNF-a, IL-6, IL-8 and IL-10 was examined 
for all agonists studied (Table 3.2).
Ligand
Cytokines
TNF-a IL-10 IL-6 IL-8
PGN V V V V
Poly I: C X X V V
LPS V y V V
Flagellin v V V V
Zymosan V V V V
R848 V V V V
LOX X X V V
ssPoly X X V V
CpG X X V V
Table 3.2 The cytokines measured fo r each o f  the ligands (Examined-V; not examined-x).
Results for cytokine production in response to all ligands are presented in Figures 3.2- 
3.9. PGN, LPS, flagellin, R848 all induced significant increase in TNF-a, IL-6, IL-8 and 
IL-10 production from placental explant cultures (n=17; p  values shown within figures). 
Notably, IL-6 and IL-8 were produced constitutively with production significantly 
enhanced by the ligands. Whilst zymosan stimulated an increase in IL-6 and IL-8 this 
was only statistically significant for IL-8 (p=0.030, Figure 3.3). As preliminary 
investigations (n=9) indicated that poly I:C, loxoribine, ssPoly and CpG did not induce 
TNF-a and IL-10 production, only IL-6 and IL-8 continued to be analysed. Whilst 
polyLC, ssPoly and loxoribine did not stimulate TNFa or IL-10 production they did 
induce significant increases in IL-6 alone (Figure 3.5), both IL-6 and IL-8 (Figures 3.9),
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and IL-8 alone (Figure 3.8), respectively. CpG (or the oligonucleotide control) did not 
stimulate production of any of the cytokines studied. Additional analysis indicated that 
R848, loxoribine, ssPoly and CpG, did not induce the production o f INF-a or IFN-y 
from the placental explants (data not shown).
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Figure 3.2 Cytokine outputs o f  placental explants in response to TLR2 ligand PG N (mean ± 
SEM; n=17). Explants were left unstimulated or stimulated with PG N  fo r  24 hours. Levels o f  (a) 
TNFa, (b) IL-10, (c) IL-6 ,and IL-8 were measured using a specific ELISA and statistically 
significant differences determined using two-tailed studen t’s t-test. p  values are as shown in red. 
p<0.05 was considered significant.
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Figure 3.3 Cytokine outputs o f  placental explants in response to TLR2 ligand zymosan (mean ± 
SEM; n=17). Explants were left unstimulated or stimulated with zymosan fo r  24 hours. Levels o f  
(a) TNFa, (b) IL-10, (c) IL-6 and (d) IL-8 were measured using a specific ELISA and statistically 
significant differences determined using two-tailed s tuden t’s t-test. p  values are as shown in red. 
p<0.05 was considered significant.
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Figure 3. 4 Cytokine outputs o f  placental explants in response to TLR3 ligand po ly I:C  (mean ± 
SEM; n=17) . Explants were left unstimulated or stimulated with poly E C  fo r  24 hours. Levels o f  
(a) IL-6 and (b) IL-8 were measured using a specific ELISA and statistically significant 
differences determined using two-tailed studen t’s t-test. p  values are as shown in red. p< 0.05 was 
considered significant.
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Figure 3.5 Cytokine outputs o f  placental explants in response to TLR4 ligand LPS (mean ± 
SEM; n=17). Explants were left unstimulated or stimulated with LPS fo r  24 hours. Levels o f  (a) 
TNFa, (b) IL-10, (c) IL-6 and (d) IL-8 were measured using a specific ELISA and statistically 
significant differences determined using two-tailed s tuden t’s t-test. p  values are as shown in red. 
p<0.05 was considered significant.
3-11
IL-
6 
pg
/m
l/0
.2
g 
tis
su
e 
— 
TN
F 
alp
ha
 
pg
/m
l/0
.2
g 
tis
su
e
(a) (b)
p=0.000014
U nstim ulated U nstim ulated
(d)
600000
800000
500000700000
p=0.000002p<0.0000001
600000 400000
500000
300000
400000
300000 200000
200000
100000
100000
U nstlm u la ted  F lagellin  U nstim u la ted  R age llin
Figure 3.6 Cytokine outputs o f  placental explants in response to TLR5 ligand flagellin (mean ±
SEM; n=l 7) . Explants were left unstimulated or stimulated with flagellin fo r  24 hours. Levels o f
(a) TNFa, (b) IL-10, (c) IL-6 and (d) IL-8 were measured using a specific ELISA and statistically
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Figure 3.7 Cytokine outputs o f  placental explants in response to TLR7/8 ligand R848( mean ±
SEM; n=17). Explants were left unstimulated or stimulated with R848for 24 hours. Levels o f  (a)
TNFa, (b) IL-10, (c) IL-6 and (d) IL-8 were measured using a specific ELISA and statistically
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Figure 3.8 Cytokine outputs o f  placental explants in response to TLR7/8 ligand loxoribine (mean 
± SEM; n=17). Explants were left unstimulated or stimulated with loxoribine fo r  24 hours. Levels 
o f  (a) IL-6 and (b) IL-8 were measured using a specific ELISA and statistically significant 
differences determined using two-tailed student’s t-test. p  values are as shown in red. p<0.05 was 
considered significant.
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Figure 3.9 Cytokine outputs o f  placental explants in response to TLR7/8 ligand (ssPoly) (mean ±
SEM; n=17). Explants were left unstimulated or stimulated with sspoly fo r  24 hours. Levels o f  (a)
IL-6 and (b) IL-8 were measured using a specific ELISA and statistically significant differences
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determined using two-tailed student's t-test. p  values are as shown in redp<0.05 was considered
significant.
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Figure 3.10 Cytokine outputs o f  placental explants in response to TLR9 ligand CpG (mean ± 
SEM; n=17). Explants were left unstimulated or stimulated with CpG fo r  24 hours. Levels o f  (a) 
IL-6 and (h) IL-8 were measured using a specific ELISA and statistically significant differences 
determined using two-tailed s tuden t’s t-test. p  values are as shown in red p<0.05 was considered  
significant.
3.3.3. Gene Expression
Transcripts for TLRs 1 - 1 0  were expressed in all of the term non-laboured placentas 
studied (n = 11). All samples were analysed using the iCycler and a representative 
example was visualised on 2% agarose gel as shown in Figure 3.11. A negative control 
(water) and a positive control (human spleen) were also included.
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Figure 3.11 PCR products obtained after gene expression analysis o f  TLRS I-10. PCR was perform ed on 
the iCycler and a representative example was visualised on a 2% agarose gel; fo r  all TLRs- Lane 1: 
Positive control (Spleen); Lane 2: Placenta; Lane 3: Negative control (water). Base pa ir ladder is shown 
at top right and bottom left corners o f  gel (range: 100-1000 base pairs with 100 base pa ir increments).
Analysis using q-PCR also provided anecdotal evidence o f relative expression by the 
placenta compared to the spleen. Ct values as shown in Figure 3.12 (a-d) indicate 
relatively increased expression o f TLR 3 and 5 by the placenta compared to spleen but 
relatively decreased expression of TLR 9 and 10. The plots for the other TLRs are in 
Appendix 6. Ct is the point at which fluorescence crosses threshold and is the average of 
each sample in triplicate. These results were confirmed in a larger sample size of non- 
laboured placentas (n=l 1, details, chapter4).
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Figure 3.12 Ct values fo r  placenta and spleen obtained using the iCycler fo r  (a) TLR3 [placenta Ct = 
23.03, spleen Ct = 28.13], (b) TLR5 [placenta Ct = 26.33, spleen Ct = 28.10], (c) TLR9 [Ct = 28.37, 
spleen Ct = 25.17], and (d) TLR10 [placenta Ct = 31.13, spleen Ct = 26.23].
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3.3 DISCUSSION
This study shows for the first time that the human term placenta can respond to a variety 
of TLR ligands additional to TLR2 and TLR4 as already described (Holmlund, Cebers et 
al. 2002; Kumazaki, Nakayama et al. 2004; Beijar, Mallard et al. 2006). Statistically 
significant increased production of at least one of the various cytokines studied (TNF-a, 
IL-6 , IL-10 and IL-8 ) was found to occur in response to ligands for TLR2, 3, 4, 5, 6  and 
7/8. Notably, a response to stimulation via TLR9 could not be detected - CpG did not 
induce any changes in cytokine outputs even though functional activity of the ligand in 
use was confirmed by its ability to induce IFNa from peripheral blood mononuclear 
cells (data from other work in the laboratory being conducted at the same time as the 
placental work). Whilst expression of transcripts for TLR 10 by the placenta was 
confirmed, however as no agonist for this receptor was available at the time of this study 
functionality could not be determined.
PGN, LPS, flagellin and R848 were able to significantly stimulate production of all four 
cytokines studied including significantly increased IL- 6  and IL- 8  in comparison to high 
constitutive levels. Even though the remaining agonists (poly I:C, a TLR3 agonist, 
loxoribine and ssPolyU, TLR7/8 agonists) variably stimulated the four cytokines studied 
these TLRs are clearly functional. Notably, the ability to stimulate cytokine production 
via TLR3 indicates that MyD8 8 -dependent and MyD8 8 -independent (presumably TRIF- 
dependent) intracellular signalling pathways are functional in the placenta (Adachi, 
Kawai et al. 1998; Akira and Takeda 2004). The discrepancies in responsiveness to the 
various TLR7/8 agonists used (loxoribine, ssPolyU and R848) could be explained by 
differences in the intracellular signalling pathways initiated by each of these ligands. In 
particular, it is now becoming clear that in contrast to R848 which stimulates both TLR7 
and 8 , loxoribine specifically stimulates TLR7 (Heil, PAhmad-Nejad et al. 2003; Levy, 
Eugenie et al. 2006) and ssPoly stimulates TLR8  .
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The inability to detect a response to CpG using the four cytokines noted above prompted 
consideration of the ability of this ligand to induce other cytokines, namely IFN-a and 
IFNy. However, neither IFNa or IFNy were detectable from untreated or CpG treated 
explants. Similarly, IFNa and IFNy could not be detected after treatment with R848, 
loxoribine or ssPoly. This is in keeping with other studies that show that IFNy is 
generally not detectable in placental tissue throughout much of pregnancy (Hanna, 
Bonifacio et al. 2004).
In accordance with published data, transcripts for TLRs 1-10 were detectable in all non- 
laboured term human placentas studied (Zarember and Godowski 2002; Nishimura and 
Naito 2005). Intriguingly, transcripts for TLR9 could be detected from all placentas 
despite the inability to detect a functional response. Further investigation of the 
regulation of expression of TLR9 protein is warranted by this finding. Also, whilst 
anecdotal, our study confirms that transcripts for TLR3 , TLR5 and TLR7 are more 
abundant in the human placenta than they are in the human spleen which is in 
accordance with reports elsewhere (Zarember and Godowski 2002).
The cytoplasmic tails of TLRs are not functionally equivalent, with certain TLRs 
requiring assembly into heteromeric complexes, whereas others are active as homomeric 
complexes. TLR2 provides a good model for this for understanding the complexity of 
TLR biology. TLR1 and TLR6  act as co receptors for TLR2 to promote or inhibit 
cellular responsiveness to activating ligands (Ozinsky, Underhill et al. 2000; Hajjar, 
O'Mahony et al. 2001). This could explain the results obtained for the TLR2 ligands 
PGN and zymosan in this study. Whilst a robust response was seen for TLR2 when 
stimulated with PGN, another TLR2 ligand, zymosan, stimulated production of all 
cytokines to a much lesser extent and this increase was only significant for IL-8 . 
TLR2/TLR1 recognises bacterial triacylated lipoproteins like peptidoglycan (Takeuchi, 
Sato et al. 2002) while TLR2/TLR6 complexes recognise mycoplasmal diacylated 
lipoproteins like lipotechoic acid, as well as fungal zymosan (Takeuchi, Kawai et al. 
2001; Morr, Takeuchi et al. 2002). Studies using macrophages showed that TLR2 needs 
a partner to activate TNF-a production in macrophages. Dimerisation of the cytoplasmic
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domain of TLR2 does not induce TNF-a production in macrophages, whereas similar 
dimerisation of the TLR4 cytoplasmic domain does. However TLR1/TLR2 
heterodimerisation overcomes the inability of TLR2 alone to produce TNF-a. Thus, the 
cytoplasmic tails of TLRs are not functionally equivalent, with certain TLRs requiring 
assembly into heterodimeric complexes, whereas others are active as homodimeric 
complexes. Therefore, more detailed analysis of TLR2 and its partner TLRs is required 
and is currently underway.
Results from this chapter clearly demonstrate that the human term placenta expresses 
functional TLR1, 2, 3, 4, 5, and 7/8 but highlights the need to undertake more detailed 
functional analysis of each of the TLR-mediated pathways in placental and other 
extraembryonic tissues. Such an analysis, of even non-functional pathways such as that 
for TLR9, would delineate the exact signalling pathways operational for each TLR 
thereby enhancing knowledge of the intrinsic differences in the activity of a particular 
receptor on stimulation with a specific ligand in a particular tissue. It may well be 
possible that in placenta, the ratio of different TLRs within a cell could modify the 
response to a given ligand (Hajjar, O'Mahony et al. 2001) and that manipulation of TLR 
activity could yield numerous therapeutic benefits.
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CHAPTER 4
CHANGES IN TLR ACTIVITY AND 
EXPRESSION IN THE PLACENTA 
WITH TERM LABOUR
4.1 INTRODUCTION
Labour is considered an inflammatory process and TLRs have a central role in the 
initiation of the inflammatory response by mediating cytokine/chemokine production (as 
discussed in Chapter 1). Therefore, TLRs might have a role in the onset and/or 
maintenance of labour. Having established that TLRs 1, 2, 3, 4, 5, 6 , 7 and 8  but not 
TLR9 are expressed and functional in the healthy term non-laboured placenta (Chapter 
3) the possibility that changes in the function and expression of these receptors are 
associated with spontaneous labour at term was explored. The review of the published 
scientific literature to date does not reveal any studies on the role of TLRs expressed by 
cells of the placenta in term labour. Studies of other gestation-associated tissues 
identified that transcripts for TLR2 and TLR4 (other TLRs were not studied) could be 
detected in amnion at term. Notably, TLR2 and TLR4 mRNA levels were significantly 
higher in choriodecidua and amnion collected after spontaneous delivery at term than 
those collected at term in the absence of labour (Kim, Romero et a l 2004).
The primary objectives of the work presented in this chapter were:
(i) To compare the functional activity of TLRs 1-9 in non-laboured and laboured 
term human placenta.
(ii) To compare the level of expression of transcripts for each TLR in the same two 
groups.
4.2 APPROACH
Placental explants from the ‘term non-laboured group’ (n=17) and the ‘term laboured 
groupy (n=17) collected after spontaneous vaginal delivery, were stimulated with 
receptor specific ligands and cytokine output measured as per Chapter 3. Differences in 
the expression of TLRs at the mRNA level in term non-laboured (n=ll) and laboured 
(n=12) human placenta was determined using real time quantitative PCR.
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Statistical comparison was made between the activities of each TLR in the two groups. 
As the data were not normally distributed the logarithmic values of the raw data were 
employed in the t-test for 2 independent samples and confidence intervals were 
calculated SPSS version 13 (SPSS Inc Chicago, USA) was used for statistical analysis. 
Similarly comparison was made between the expressions of each TLR in the 2 groups by 
using the Mann Whitney U test for two independent samples and SPSS version 13.
4.3 RESULTS
4.3.1 Comparison of activity of TLR 1-10 between non-laboured and laboured 
groups
As this component of the study generated a large volume of data, preliminary analysis 
was undertaken using forest plots for each of the cytokines assayed (Figure 4.1a-d). 
Each forest plot shows the results for each of the different ligands used to induce the 
cytokine in question. The midpoint on each horizontal bar is the mean difference 
between the laboured and non-laboured samples and the horizontal cross bars represent 
the upper and the lower confidence intervals of the mean difference. A statistically 
significant result is identified when the confidence intervals remain entirely on one side 
of the mid line. In this case if the confidence intervals remain entirely on the right hand 
side, cytokine outputs from the laboured samples were greater than non-laboured 
samples. These plots revealed that the TLR-mediated cytokine outputs that differed 
significantly between the laboured and non-laboured groups were TNFa production in 
response to LPS (TLR4 ligand; p=0.01) and R848 (TLR7/8 ligand; p=0.01) (Figure 4.2 a 
& b). The plots for the other TLRs are in Appendix 7. Table 4.1 shows the results of the 
statistical analysis for all the cytokine/ligand combinations studied.
4-3
(a) (b)
♦ LPS
H#H
I-----• -----1
■ PGN
I----A ----1 -A - Zymosan
K h
I— X —I
o Flagellin
|-#H X R848
-1 0 1
• Unstimulated
(c)
♦ LPS
■ PGN
h#H
i-B h A Zymosan
HAH X Flagellin
P *
i Nl/ i1 Svk 1
X R848
h#H • Lox
1— 1—1 
HAH
+ l:C
1—© —1 CpG
HAH o ssPoly
-1 0 1 -♦  - Unstimulate
I-----A -----1 A LPS
I----- ♦ — H ♦  - PGN
----1 ■ Zymosan
i— —+ — Flagellin
I--------X r------ 1
X R848
I—0 —H
• — Unstimulated
-1 -0 .5  0 0.5 1
(d)
♦  R848
h-A-
- Lox
t—B—H
l i l
X CpG
H-X — l x ssFbly
— A----------1
-A — Unstimulat
ed
Figure 4.1 Horizontal confidence interval plots fo r  the effects o f  labour on the response to each TLR 
ligand as measured by cytokine output. Each forest p lo t shows the results fo r  each o f  the different ligands 
used to induce (a) TNFa, (b) IL-10, (c) IL-6, and (d) IL-8. The midpoint on each horizontal bar is the 
mean difference between the laboured and non-laboured samples and the horizontal bars represent the 
upper and the lower confidence intervals o f  the mean difference.
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Figure 4.2 TNFa production in response to (a) LPS and (b) R848 stimulation o f  non-laboured (n=17) and  
laboured (n=17) placental explants. Cytokine levels after 24 hours incubation were compared using Mann 
Whitney U test fo r  two independent samples (p values are shown on the graphs).
TLRs TNFa IL - 6 IL - 8 IL-10
TLR2 (PGN) 0.543 0.069 ND 0.091
TLR3 (Ploy I:C) ND 0.617 ND ND
TLR4 (LPS) 0.010 0.482 ND 0.683
TLR5 (Flagellin) 0.389 0.863 ND 0.636
TLR2/6 (Zymosan) 0.109 0.702 ND 0.735
TLR7/8 (R848) 0.010 0.095 0.180 0.547
TLR7/8 (sspoly) ND 0.789 0.202 ND
TLR7/8(loxoribine) ND 0.523 0.232 ND
TLR9 (CpG) ND 0.341 0.950 ND
Unstimulated 0.125 0.356 0.547 0.223
Table 4.1 Summary o f  the p  values obtained after statistical analysis o f  the cytokine outputs obtained fo r  
each cytokine in response to each TLR ligand in the non-laboured (n -  17) and laboured (n = 17) groups. 
ND -  not done
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4.3.2 Comparison of the expression of mRNA for TLR 1-10 between the non- 
laboured and laboured groups
Data were obtained using iCycler software (Details in Chapter 2) and Ct values obtained 
from all samples were imported into qbase (Version 1.2.2). This software 
(http://medgen.ugent.be/qbase/) enabled a normalisation factor allowing for plate-to- 
plate variation/efficiencies of all genes but especially the three house keeping genes to 
be incorporated into any calculations. Thereby relative gene expression of the genes of 
interest could be calculated (Vandesompele, De Preter et al. 2002). All results were 
normalised against the lOOOng/ml placental sample. Testing of commonly used 
endogenous control genes such as GAPDH (glyceraldehyde-3-phosphate 
dehydrogenase) and p-actin show that their level of expression is affected by a number 
of conditions including different endocrine and immune system changes which happen 
normally in pregnancy. It is for this reason that succinate dehydrogenase complex, 
subunit A (SDH A); TATA box binding protein (TBP); tyrosine 3- 
monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide 
(YWHAZ) were used as the housekeeping genes as these are relatively stable (Meller, 
Vadachkoria et al. 2005). Results for expression of mRNA for TLR1-10 in the 2 
experimental groups, non-laboured (n = ll) and laboured (n=12), are shown in Figure 4.3 
a-j. The p  values are shown within the figures. Generally the expression of all TLRs 
was greater in the laboured than the non-laboured group however a statistically 
significant increase in association with labour was seen only for TLR2 and TLR5.
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Figure 4.3 Box and whisker plots depicting comparison between expression o f  mRNA fo r  TLRs I-10 in the 
term-non-laboured (n = ll)  and term laboured (n=12) groups. M ann Whitney U test fo r  two independent 
samples was employed and the p  values are shown on the graphs.
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4.4 DISCUSSION
The extensive analysis of differences in the functional response of laboured and non- 
laboured term placentas to various TLR ligands revealed statistically significantly 
increased levels of TNFa in response to a TLR4 ligand (LPS) and a TLR7/8 ligand 
(R848) in the laboured group. However, this change in function was not explained by an 
increase in the level of transcripts for these two TLRs in the laboured group. Whilst, 
placental levels of transcripts for TLR4, TLR7 and TLR8  did not change with labour, 
TLR2 mRNA and TLR5 mRNA were significantly higher in the laboured group despite 
no functional changes in the cytokine output in response to stimulation via these 
receptors being detected.
Although a wide range of TLRs were found to be expressed in the term human placenta 
it seems that the function of only TLR4 and TLR7/8 might differ with labour. Whilst 
there is ample evidence in the literature regarding amplified cytokine responses with and 
without stimulation by, typically, LPS in gestational tissues following labour (Laham, 
Brennecke et al. 1994; Laham, Brennecke et al. 1996; Laham, Brennecke et al. 1996; 
Laham, Brennecke et al. 1999; Elliott, Loudon et al. 2001) these generally relate to the 
study of the amnion and/or choriodecidua. Although these tissues are being studied by 
the group, the placenta formed the focus of this project. Studies by other groups of the 
effect of labour on cytokine production by the term placenta have yielded similar results 
to those presented herein. Although TNFa as well as IL-la and IL-lft were all 
significantly up-regulated in placentas from normal term pregnancies in response to 
labour-associated conditions, the constitutive and/or LPS-stimulated production of IL-6 , 
IL- 8  and IL-10 by the placenta does not differ “before” and “after” labour (Laham, 
Brennecke et al. 1996; Laham, Brennecke et al. 1999; Hanna, Hanna et al. 2000). 
Furthermore whilst the expression of IL-10 (measured using quantitative PCR) by the 
placenta declined over gestation it did not differ “before” and "after" labour at term. 
These results suggest that IL-10 expression remains at lower levels during labour to 
allow parturition-associated pro-inflammatory cytokines to be over-expressed. Notably,
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IL- 6  levels were significantly higher in amniotic and choriodecidual but not placental 
cultures obtained after the completion of labour at term compared to samples taken at 
the time of elective caesarean section at term (Laham, Brennecke et al. 1996). Also 
similar to our findings spontaneous onset of labour, irrespective of the eventual mode of 
delivery, was not found to be associated with any significant changes in IL- 8  release 
from the amnion, choriodecidua, and placenta tissues compared to not in labour tissues 
both at term and preterm (Laham, Brennecke et al. 1999).
The explanation for the significant increase in TNFa in this and other studies and not 
other proinflammatory mediators might relate to the fact that IL- 6  and IL- 8  are produced 
constitutively by the placenta. It could also be that the levels of immunoreactive IL- 6  
and IL- 8  as measured by ELISA, remain the same and rather it is their bioavailability 
that changes favourably. For example, IL- 8  binds macromolecules that affect its activity 
such that the total amount of IL- 8  can remain the same but its functional activity is 
altered by the release of the chemokine from macromolecules that otherwise inhibits its 
activity (Mire-Sluis AR 1997). This possibility is now being explored. Another possible 
explanation is that measurements can only be made before the onset (elective caesarean 
sections) and after the completion (vaginal deliveries). Although inclusion of samples 
from women who have been in labour but have had to undergo emergency caesarean 
section before the natural completion of labour might resolve this issue, the variable 
reasons for emergency delivery of the baby might confound any results.
In contrast to the lack of differences between TLR2 and TLR4 mRNA in the laboured 
placenta, increases in both TLR2 and TLR4 mRNA have been described in 
chorioamnion collected after the completion of spontaneous labour at term compared to 
that collected in the absence of labour (Kim, Romero et al. 2004). Changes in TLR2 and 
TLR4 expression associated with labour might therefore be tissue specific as no 
difference in transcripts were seen in either the placenta (this study) or in the 
myometrium before and after the completion of labour in humans (R Youssef 2006).
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Data about protein expression of the receptors themselves or the intracellular signalling 
pathways being utilised should enhance our understanding of the contribution of TLR- 
dependent processes to parturition. Changes in receptor expression have been identified 
in the placenta and thus TLRs might have a role in pathological inflammatory conditions 
within the gestation associated tissues, particularly infection-associated preterm labour 
and preeclampsia, as discussed in Chapter 5. A study of preterm placentae with 
chorioamnionitis revealed that the inflammatory cells infiltrating the placenta expressed 
TLR4, and that TLR4 expression on the villous Hofbauer cells was increased in 
comparison to preterm placenta without chorioamnionitis as well as term placentae 
(Kumazaki, Nakayama et al. 2004). TLR4 protein expression by interstitial trophoblast 
is also increased in preeclampsia (Kim, Romero et al. 2004; Kim, Romero et al. 2005).
These observations reflect the complexity and interplay between TLR signalling 
pathways and support a lack of relationship between protein and mRNA levels for 
TLRs, at least in the placenta, and/or a role for various regulatory mechanisms including 
those that are TLR-independent to explain the changes in LPS and R848 mediated TNFa 
production. In summary, whilst the human term placenta expresses a variety of 
functional TLRs and labour-associated changes do occur, a more detailed analysis of 
contributing cell types and signalling molecules is required to elucidate the role of this 
family of receptors in parturition.
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CHAPTER 5
TLR EXPRESSION AND RESPONSE 
BY THE PLACENTA IN PRETERM
LABOUR
5.1 INTRODUCTION
An extensive literature highlights the probable contribution of cytokines and chemokines 
to infection-associated preterm labour (IA-PTL) (Gomez, Ghezzi et al. 1995; 
Goldenberg and Rouse 1998; Lamont 2003). In particular, elevated levels of IL-6 , IL- 8  
and TNFa are measurable in amniotic fluid, choriodecidual tissue and maternal plasma 
from deliveries characterised by infection-associated preterm labour (Mitchell, Trautman 
et al. 1993; Laham, Brennecke et al. 1996; Laham, Brennecke et al. 1999). These effects 
can be replicated in vitro by treatment of the placenta, choriodecidua or amnion with the 
microbial product LPS. The Asp299Gly TLR4 gene polymorphism which is associated 
with impaired TLR4 receptor function and an increased likelihood of Gram-negative 
sepsis (Agnese, Calvano et al. 2002) also has been shown to be carried more often by 
preterm infants than term infants or by mothers delivering preterm rather than at term 
(Lorenz, Hallman et al. 2002). Unpublished data referred to by this same group highlight 
that studies should not be restricted to TLR4 as in the same Finnish population there was 
a trend towards higher frequency of TLR2 mutations in preterm compared with term 
infants.
Thus TLRs within the gestation associated tissues might have a role in pathological 
inflammatory conditions, particularly infection-associated preterm labour and 
preeclampsia. To date, a study of preterm placentae with chorioamnionitis revealed that 
the inflammatory cells infiltrating the placenta expressed TLR4, and that TLR4 
expression on the villous Hofbauer cells was increased in comparison to preterm 
placenta without chorioamnionitis as well as term placentae (Kumazaki, Nakayama et al. 
2004). TLR4 protein expression by interstitial trophoblast is also increased in 
preeclampsia (Kim, Romero et al. 2004; Kim, Romero et al. 2005).
Over the past few years there has been a dramatic increase in interest and information 
about activity mediated by microbial ligands/TLR combinations in various tissues and
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diseases. However, there is little information about the possible role of these ligands and 
receptors in infection associated preterm labour. As TLRs (with the exception of TLR9) 
were found to be functional in the term placenta and stimulation via TLRs could lead to 
the production of relevant cytokines and chemokines an investigation of the activity of 
TLRs in preterm placentas was undertaken.
The primary objectives of the work presented in this chapter were:
(i) To evaluate the functional activity of TLRs 1-9 in the human preterm 
placenta.
(ii) To confirm the presence of transcripts for each TLR in the human preterm 
placenta.
(iii) To evaluate the expression and/or activity of TLRs in infection-associated 
preterm labour in comparison with term labour.
5.2 APPROACH
Placentae (n=15) were obtained following preterm labour at varying gestations for 
various reasons. Explant cultures were prepared and treated with TLR ligands as before 
{Chapter 3 and 4). Cytokine output in response to stimulation was then an index of the 
capacity of the placenta to signal its response via that specific TLR. The expression of 
transcripts of TLRs in the preterm human placenta was also determined by qPCR 
(n=12). The TLR activity and expression in the preterm group was compared with the 
term laboured group. Statistical comparison between the activities and expression of 
each TLR in the 2 groups was performed using the Mann Whitney U test fo r two 
independent samples and SPSS Version 13 (SPSS Inc Chicago, USA).
5-3
5.3 RESULTS
5.3.7 Characteristics of preterm samples
The placentae in the study were obtained following preterm labour at varying gestations, 
ranging from 25 weeks to 36 weeks. Eleven of the 15 cases delivered vaginally and the 
other 4 underwent elective caesarean section. All 4 cases delivered by caesarean section 
were for maternal (preeclampsia) or fetal reasons (IUGR). One case from the vaginal 
delivery group was induced prematurely at 35 weeks due to preeclampsia and the 
remaining 1 0  cases which delivered vaginally after spontaneous onset of labour had no 
obvious matemo-fetal reasons to explain the premature delivery. On checking the 
medical records of these 1 0  cases, evidence of infection was found in most cases either 
in the form of histologic chorioamnionitis, positive swabs, urine examination or blood 
markers of infection as shown in Table 5.1.
Case
Number
Gestation in 
weeks
Mode of delivery Reason for delivery Evidence of infection
1 25 SVD IAPTL Funisitis
2 26 SVD IAPTL Urinary infection
3 27 SVD IAPTL Raised White cell count
4 31 SVD IAPTL None
5 33 SVD IAPTL GBS on swabs
6 33 SVD IAPTL Histologic
Chorioamnionitis
7 34 SVD IAPTL Raised CRP
8 36 SVD IAPTL Coliforms on swabs
9 36 SVD IAPTL Raised White cell count
10 36 SVD IAPTL Urinary infection
11 35 SVD (induced) Pre eclampsia None
12 32 Caesarean Pre eclampsia None
13 31 Caesarean IUGR None
14 33 Caesarean IUGR None
15 36 Caesarean Maternal Glaucoma None
Table 5.1 Characteristics o f preterm samples.
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5.3.2 Comparison of TLR activity between the IA-PTL group and the term 
laboured group
As the preterm samples were a heterogeneous group and of varying gestations, an initial 
comparison o f the cytokine outputs from the 10 placentae obtained following suspected 
IA-PTL (preterm-SVD) was made with term laboured group (term laboured) (Figures
5.1 a -  h). The concentration o f TN Fa and/or IL-6 was statistically significantly reduced 
in preterm samples (n = 10) compared with term samples (n = 17) treated with PGN 
(TLR2) poly I:C (TLR3), LPS (TLR4), flagellin (TLR5), R848 (TLR7/8) but not 
zymosan or loxoribine (TLR7/8) (p values shown on graphs). None o f the preterm 
samples responded to CpG. Constitutive production o f IL-6 was also significantly 
reduced in the preterm samples (p = 0.023; Figure 5.2). In contrast, irrespective o f the 
TLR ligand used, IL-10 production did not differ significantly between term and preterm 
samples.
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Figure 5.1 Comparison o f  cytokine outputs (TNFa, IL-6 and IL-10) from  placental explants o f  term- 
laboured (n=17) versus preterm-SVD (n -1 0 ) in response to (a) PGN, (b) LPS, (c) flagellin, (d) 
zymosan, (e) R848 (f) poly I:C, and (g) loxoribine. Mann Whitney U test fo r  two independent samples was 
employed fo r  statistical analysis, p  < 0.05 was considered to be significant.
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Figure 5.2 Comparison o f  IL-6 levels produced const itutively from  placental explants o f  term laboured (n 
= 17) versus preterm-SVD (n = 10). Mann Whitney U test fo r  two independent samples was employed fo r  
statistical analysis, p  < 0.05 was considered to be significant.
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5.3.3 Effect of Dexamethasone on cytokine output of pretrm placental explants
As all the subjects in the IA-PTL group received steroids as part o f the clinical therapy 
for preterm labour, the effect of dexamethasone (steroid) treatment on TLR-stimulated 
cytokine output by the placenta was explored. Placental explants prepared from non- 
laboured term deliveries (elective caesarean section) were treated with dexamethasone 
and IL-6 outputs in response to all TLR ligands determined. IL-6 was chosen as it can be 
induced by all ligands studied and is produced constitutively. Constitutive and TLR 
ligand-stimulated IL-6 was reduced in the presence of dexamethasone for all TLR 
ligands (only LPS, flagellin and Poly I:C are shown) (Figure 5.3 a-d). The reduction in 
the cytokine output following treatment with dexamethasone was significant with p 
values of <0.0001 for both the constitutive and ligand-stimulated explants (with 
exception of 1/0.4 versus 1/0 and F/0.4 versus F/0).
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Figure 5.3 Effect o f  dexamethasone on IL-6 production by placental explants. Explants were prepared  
from  term non-laboured placentas and treated with 0.4, 4 and 40 ng/ml dexamethasone in the presence o f  
various TLR ligands. Supernatants were harvested after 24 hours and IL-6 (mean ± SEM) production in 
response to (a) no stimulation/constitutive, (b) LPS, (c) flagellin, (d) Poly I:C  determined by ELISA.
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5.3.4 Effect of pre-exposure to TLR ligands on TLR ligand stimulated cytokine 
output of placental explants
As the 10 preterm-SVD placentas came from deliveries associated with intrauterine 
infection it was possible that they were exposed in utero to one or more of the TLR 
ligands used in this study. Pre-exposure to LPS is known to reduce the level of response 
upon secondary exposure to LPS, a process known as endotoxin tolerance (Broad A 
2006). Therefore it was postulated that pre-exposure to any one ligand could explain the 
reduced cytokine outputs (at least for IL- 6  and TNFa) in response to all ligands in the 
preterm group. Therefore, placental explants prepared from term non-laboured placenta 
were exposed to each TLR ligand and after 24 hours culture the first dose of ligand was 
removed by centrifugation and the tissue recultured in fresh medium in the presence of 
the same or another TLR ligand. After a further 24 hours culture, supernatants were 
harvested and analysed for IL-6 . Data obtained for unstimulated, LPS, PGN and 
Flagellin are shown in Figure 5.4 a-d. This approach did not reveal any consistent trend 
in the cytokine output although reduced outputs were not an overarching feature. Thus 
prior intrauterine exposure to the ligand does not explain the reduced cytokine output of 
preterm placental explants in comparison to term explants.
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Figure 5.4 Effect o f  pre-exposure to TLR ligands on TLR ligand stimulated cytokine output o f  placental 
explants. Explants were prepared from  term non-laboured placentas and treated with TLR ligands.. 
Supernatants were harvested after further 24 hours and IL-6 (mean ± SEM) production in response to (a) 
constitutive (Cons)/no stimulation , (b) LPS, (c) PGN, (d) Flagellin determined by ELISA (where standard  
error bars are missing the errors are too small to show)
5.3.5 Comparison of mRNA for TLR1 - TLR10 between term laboured and 
preterm laboured groups.
As preterm samples were of varying gestations and for various reasons, initial 
comparison of the TLR transcripts was made between the preterm spontaneously 
laboured group (obtained following IA-PTL, preterm-svd, n=9) and the term laboured 
group (term-laboured, n=J2; Figures 5.6 a -  j). Placental biopsies from all deliveries
(K)were placed in RNAlater so although RNA extraction, cDNA synthesis and PCR could 
not be conducted simultaneously they were spread over three mixed batches for 
extraction and cDNA synthesis and 2 plates PCR as described in detail in Chapter 2, 
section 2.5.3). The expression o f TLR transcripts by the two groups did not differ 
statistically for any of the TLRs (p values shown on graphs).
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Figure 5.6 Box and whisker plots depicting comparison between expression o f  mRNA fo r  TLRs 1-10 in the 
term-laboured (T) (n=12) and preterm-SVD (P) (n =  9) groups. Mann Whitney U test fo r  two independent 
samples was employed and the p  values are shown on the graphs.
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5.4 DISCUSSION
IL - 6  and TNFa outputs after stimulation of the placenta via TLR2, TLR3, TLR4, TLR5 
and TLR7/8 were significantly reduced in the preterm compared with term laboured 
group. As for the term group, TLR9 activity was not detected. Despite these functional 
differences on comparison with the term group there were no differences in the levels of 
mRNA for any of the TLRs studied. This is similar to the results obtained in Chapter 4 
in which there was no apparent correlation between functional output and mRNA levels 
for any of the TLRs (in the term laboured and non-laboured groups). The comparable 
levels of placental TLR transcripts in the preterm and term laboured groups is also 
similar to findings in human myometrium where both TLR2 and TLR4 mRNA 
expression was comparable in labouring versus nonlabouring myometrium both at term 
and preterm gestations (R Youssef 2006). These results suggest that TLR protein 
expression should be studied in greater detail and/or that changes in inhibitors of TLR- 
dependent signalling might have a critical role.
A number of inhibitors of TLR-mediated activity have now been described. Over­
expression of Tollip (toll interacting protein) results in impaired NF-kappaB activation 
(Bums K 2000) which can thus diminish the TLR response and thus the cytokine output. 
Similarly SIGGR (single immunoglobulin IL-lR-related molecule), acts as a negative 
regulator of interleukin (IL)-l and lipopolysaccharide (LPS) signaling (Wald D 2003; 
Qin J 2005; Huang X 2006).Thus investigation of the relative expression of these 
inhibitors in preterm versus term tissues might prove fruitful.
One of the challenges of undertaking studies such as this in humans is that it is 
impossible to obtain samples during labour and samples can only be obtained once the 
delivery is completed. Consequently, results obtained at this time might not be 
representative of the response occurring in utero earlier in labour. Additionally, women 
in preterm labour are treated with various pharmacotherapies to (i) prevent premature 
delivery (tocolytics) and (ii) prepare the baby for premature delivery (corticosteroids).
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Therefore to explore the possibility that these treatments might explain the results 
obtained in this chapter, a number of additional studies were undertaken. Firstly, the 
effect of dexamethasone on TLR-mediated responses was explored. The constitutive and 
TLR ligand-stimulated IL- 6  was reduced in the presence of dexamethasone for all TLR 
ligands studied and the reduction in the cytokine output following treatment was 
statistically significant with doses of 4 and 40ng/ml of dexamethasone.
Secondly, the possibility that previous stimulation of a TLR (i.e. in utero) might down- 
regulate secondary responses (i.e. in vitro) was considered. This could be because of 
exhaustion or downregulation of the relevant TLR pathways in vivo as a result of 
response to the presence of infection. Pre-exposure to LPS is known to reduce the level 
of response upon secondary exposure to LPS, a process known as endotoxin tolerance 
(Fan and Cook 2004; Broad, Jones et al. 2006). Endotoxin tolerance is a well known 
phenomenon, described both in vivo and in vitro, in which repeated exposure to 
endotoxin results in a diminished response, usually characterised as a reduction in pro- 
inflammatory cytokine release. With increasing understanding of the part played by 
TLR-4 signalling in endotoxin/LPS release it has become clear that response tolerance 
occurs to other TLR ligands in addition to LPS/endotoxin. However, pre-treatment of 
explants from non-laboured term placentas with any TLR ligand in vitro was not 
associated with diminished responses to any TLR ligand. Thus prior intrauterine 
exposure to the ligand does not explain the reduced cytokine output of preterm placental 
explants in comparison to term explants.
In keeping with findings from the term placenta as discussed in chapter 3 and 4, results 
from this chapter clearly demonstrate that the human preterm placenta also expresses 
functional TLR1, 2, 3, 4, 5, and 7/8. However contradictory to the assumption that 
preterm labour would be associated with enhanced cytokine levels secondary to its 
infection related etiology, we found reduced cytokine output in the preterm samples in 
comparison to term samples. This does not appear to result from a mechanism similar to 
endotoxin tolerance and whilst it could reflect exposure to steroids this reduced output 
by the preterm placenta might also be due to overexpression of TLR inhibitors. Further
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studies to determine expression of inhibitors of TLR activity would be worthwhile 
pursuing.
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CHAPTER 6 
CONCLUSIONS
6.1 INTRODUCTION
Toll like receptors have emerged as key upstream mediators of inflammation at many 
tissue sites in humans. Parturition is considered an inflammatory process so it was 
hypothesised that TLR activity within gestation-associated tissues, such as the placenta, 
might have an important role in the initiation and/or maintenance of labour and in 
various pathological states of pregnancy such as infection associated preterm labour.
The study reported in this thesis examined the expression and the activity of the TLRs in 
the preterm and term laboured and non-laboured human placenta. The underlying aim of 
the study was to achieve a better understanding of the mechanisms which underlie the 
onset of labour whether at term or preterm. Understanding TLR-mediated inflammation 
at the matemo-fetal interface is of relevance to labour and could reveal novel targets for 
either the prevention of labour when preterm or induction of labour at term. The former 
is a priority of contemporary obstetrics.
Despite much effort during the past 40 years in tackling preterm labour, this remains the 
most important cause of perinatal mortality and morbidity. Prematurity alone accounts 
for 75% of perinatal morbidity and mortality in the developed world (Besinger 1993). If 
the problem of prematurity is to be tackled successfully, there are three facets to 
consider -  firstly, and ideally, the prevention of preterm labour, or failing that successful 
recognition and implementation of treatment directed at inhibiting myometrial 
contractions, and lastly the care of the preterm newborn. With the advances made so far, 
the prevention of preterm labour seems to be the most viable step in dealing with the 
problem of prematurity. Certainly this requires a better understanding of the basic 
etiology of preterm labour. With this background, this study was planned and was 
commenced with the determination of baseline characteristics at the matemofetal 
interface in the non-laboured state. This then progressed to evaluation of the changes 
with onset of labour at term and finally to the changes in association with the preterm 
labour.
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6.2 MAIN CONCLUSIONS OF THIS STUDY
6.2.1 TLR expression and activity in the human placenta
This study describes the expression of transcripts for TLRs 1-10 in the term human 
placenta in keeping with published studies (Zarember and Godowski 2002; Nishimura 
and Naito 2005). With the exception of TLR9 (and TLR10 which could not be studied) 
all TLRs were found to be functional. However further study is required to determine the 
activity of TLR1 and TLR2; and TLR2 and TLR6  heterodimers. Our study indicated 
differential response on stimulating TLR2 with different ligands (PGN and zymosan). 
Thus, the cytoplasmic tails of TLRs are not functionally equivalent, with certain TLRs 
requiring assembly into heterodimeric complexes, whereas others are active as 
homodimeric complexes. Therefore, more detailed analysis of TLR2 and its partner 
TLRs is required and is currently underway. Also the recent development of TLR7 and 
TLR8  specific ligands in contrast to R848 used in this study which stimulates both 
TLR7 and TLR8  means more detailed study of these pathways should now be possible. 
Ideally these studies should be complemented with analysis of protein expression (e.g. 
immunohistochemistry and/or immunoblotting). However the lack of antibodies suitable 
for anything other than TLR2 and TLR4 at the time of study precluded such analysis but 
is an ongoing aim of the group.
6.2.2 Changes in TLR response and expression in term labour
The extensive analysis of differences in the functional response of laboured and non- 
laboured term placentas to various TLR ligands made in this study revealed statistically 
significant increased levels of TNFa in response to a TLR4 ligand (LPS) and a TLR7/8 
ligand (R848) and of transcripts for TLR2 and TLR5 in the laboured group. Changes in 
TLR4 mediated and TLR7/8 mediated function was not accounted for by an increase in 
the level of transcripts for these two TLRs. This discrepancy could be due to changes in
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the protein expression of the TLRs themselves of any of the accessory molecules known 
to modify their activity, e.g. CD 14 for TLR4 mediated responses. As noted above, the 
recent availability of TLR7 or TLR8  specific ligands means that further studies should 
reveal if labour associated changes are peculiar to just one of these receptors.
623  TLR expression and response in preterm labour
The primary objective of this component of the study was to elicit the possible etiology 
of preterm labour at the cellular level. Cytokine levels (TNFa and IL- 6  but not IL-10) in 
response to stimulation via TLR2, 3, 4, 5 and 7/8 were significantly reduced in placentae 
obtained after preterm labour compared with those obtained after term labour. However 
tie expression of transcripts for these TLRs did not differ between the two groups. 
Reduced concentration in the absence of changes in levels of transcripts might be 
eiplained by steroid exposure as most patients with preterm labour received steroid 
iijections as part of the treatment for preterm labour. In support of this, dexamethasone 
tieatment reduced IL- 6  output via all ligands as well as constitutively. However the 
physiological significance of this remains unknown. Alternatively, pre-exposure to any 
TLR stimuli in utero might lead to the downregulation of the receptors leading to 
reduced output of cytokines on their subsequent stimulation. However the data generated 
cb not support this. Another possible explanation is that TLR pathway inhibitory 
nolecules, such as Tollip, SIGGR and other similar inhibitory molecules are relatively 
o/er expressed in the preterm placenta and this possibility is worthwhile investigating.
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6.3 SUMMARY
This study clearly demonstrates that the human term placenta expresses functional 
TLR2, 3, 4, 5, 7 and 8  and, because of the observed response to PGN, TLR1 must also 
be active (Takeuchi, Sato et al. 2002). This study also highlights the need to undertake 
more detailed functional analysis of each of the TLR-mediated pathways in placental 
and other extraembryonic tissues. Such an analysis, of even non-functional pathways 
such as that for TLR9, would delineate the exact signalling pathways operational for 
each TLR thereby enhancing knowledge of the intrinsic differences in the activity of a 
particular receptor on stimulation with a specific agonist in a particular tissue. It might 
well be possible that in placenta, the ratio of different TLRs active within different cell 
populations could modify the response to a given agonist (Hajjar, O'Mahony et al. 2001) 
and that manipulation of TLR activity could indeed yield numerous therapeutic benefits.
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CHAPTER 7 
FUTURE DIRECTIONS
FUTURE WORK
The study in this thesis has concentrated on the function of TLRs in the placenta by 
measuring the biological activity of these receptors on stimulation with their agonists 
using cytokine outputs measured by ELISA. At the same time gene expression studies 
were also performed to illustrate the expression of TLRs at the mRNA level.
This work has demonstrated that these receptors are both present and functional in the 
human placenta. This is a novel finding and an extension to previously reported studies 
(Holmlund, Cebers et a l 2002; Zarember and Godowski 2002; Kim, Romero et a l 
2004; Kumazaki, Nakayama et a l 2004). Changes in TLR activity and expression in 
response to term and preterm labour have also been shown. In general, these findings 
indicate that there is no relationship between mRNA expression and function of these 
receptors within the placenta indicating that specific inhibitory mechanisms and/or TLR- 
independent mechanisms might supplement TLR-dependent activity. Thus the human 
term placenta expresses a variety of functional TLRs but more detailed analysis of 
contributing cell types and signalling molecules is required to elucidate the role of this 
family of receptors in parturition.
Future work should, in particular, aim to determine the protein expression of TLR 1/2/6, 
TLR4 and TLR7/8 receptors by using immunohistochemistry and/or immunomodulatory 
studies (of course, once a TLR 10 ligand is identified, functional activity of this receptor 
pathway should be determined). More detailed analyses of the TLR4 and TLR7/8 
signalling pathway could explain why increased TLR activity occurs in absence of any 
change in the expression of the mRNA for these TLRs with the onset of term labour. 
Moreover, elucidating the complexity in the TLR2 singalling pathway might explain 
why increased TLR2 mRNA expression is increased with labour in the apparent absence 
of any functional changes in TLR2-meidated cytokine outputs. There may also be 
changes in the expression of accessory molecules like CD 14 which could explain 
increased activity in response to LPS. Notably, expression of soluble CD 14 and soluble 
TLR2 was demonstrated using immunoblotting during the course of this study.
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Furthermore it would be worthwhile to look at other gestational tissues such as amnion 
as altered activity of this tissue is likely to contribute to changes in the cytokine profile 
of amniotic fluid. Of note, this work revealed a reduced cytokine output following 
stimulation of TLRs after preterm labour and, as already underway, the study of both 
protein expression levels and inhibitory pathways is warranted.
Several lines of evidence support a genetic predisposition to spontaneous preterm labour 
and preterm birth. A leading risk factor for spontaneous preterm labour and preterm 
birth is a personal or family history. If a woman previously delivered preterm, her 
subsequent babies are also more likely to be bom preterm. Women who experienced an 
early preterm birth (<32 completed weeks) in their first pregnancy have the highest rate 
of recurrent preterm birth in subsequent pregnancies. Spontaneous preterm labour and 
preterm birth in subsequent pregnancies tend to recur at equivalent gestational ages. If a 
woman herself was bom preterm, she is also at an increased risk of spontaneous preterm 
labour and preterm birth, with the risks being highest for those women who themselves 
were bom most preterm. This predisposition does not apply if the father was bom 
preterm. Thus a genetic approach might provide important information regarding an 
individual's susceptibility towards preterm labour. Polymorphisms in TLR2 and 4 in 
both mother and fetus have been identified and have been linked with altered 
responsiveness to TLR ligands and these genetic mutations might have an impact 
clinically (Lorenz, Hallman et al. 2002; von Aulock, Schroder et a l 2004).
Furthermore, it is well established that upper genital tract infection and/or inflammation 
is seen in association with spontaneous preterm labour and preterm birth. Previous 
investigations have focused primarily on an infectious aetiology for this finding. In 
keeping with our hypothesis that preterm labour represents an abnormal inflammatory 
response (histological evidence of infection/inflammation and elevated body fluid 
concentrations of inflammatory cytokines) investigations have been performed on single 
gene polymorphisms of relevant cytokines in both mother and fetus. The polymorphisms 
TNFa-308, IL-ip+3953/3954 and IL-6-174 have been most consistently associated with 
spontaneous preterm labour and preterm birth (Varner MW 2005). These findings
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confirm a clear genetic predisposition to spontaneous preterm labour and preterm birth 
and raise hopes that patient-specific therapies might be developed in the future. Focusing 
on functional responses of gestation-associated tissues from women of known genotype 
might be of interest. Similarly polymorphisms in other TLRs like TLR5 and TLR7/8 
could be of interest.
Toll-like receptors could also play a role in the pathogenesis of certain pregnancy 
complications in addition to preterm labor such as preeclampsia or IUGR. If this is the 
case then these receptors might be used as clinical biomarkers of disease. Recently, 
soluble TLR2 has been identified (LeBouder, Rey-Nores et al. 2003) and has been 
postulated to modulate specific TLR mediated responses. Alternatively, soluble forms of 
TLRs might bind to microorganisms and flag them for destruction by the complement 
system or by phagocytosis (Medzhitov and Janeway 2002). Soluble Toll-like receptors 
might, therefore, provide new markers of pregnancy complications as well as a potential 
target for therapeutic interventions.
\
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Appendix 1
CONSENT FORM
VERSION NO: 2 (12/08/04)
LREC number 04/WMW02/18
Patient identification number for this trial................................
N.B. Three copies should be made for (1) patient, (2) researcher, (3) hospital
notes
Title of project : Maternal allergy and smoking and the immune response of the
newborn.
Name of researcher : Catherine Thornton, PhD
Contact telephone number: 01792 602122
Please initial Box
1. I confirm that I have read and understood the information sheet 
for the above study and have had the opportunity to ask questions.
2. I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason, without my 
medical care or legal rights being affected.
3. I understand that sections of any of my medical notes may be looked 
at by responsible individuals from University of Wales Swansea,
Swansea NHS Trust or from regulatory authorities where it is relevant 
to my taking part in research. I give permission for these 
individuals to have access to my records.
4. I agree to take part in the above study.
Name of Patient Date Signature
Name of Person taking consent Date Signature
Researcher Date Signature
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6
7
8
9
10
11
12
13
14
15
16
17
1
2
3
4
5
6
7
8
9
10
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13
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2
3
4
5
6
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Appendix2
Details of experimental Groups
Group Maternal Age (years) Parity Gestation(weeks) Birth weight(grams) Gender
EL CS 30 1+0 39 3890 Female
EL CS 29 3+0 39 2890 Male
EL CS 31 0+0 42+ 3460 Female
EL CS 31 1+0 40+1 4450 Male
EL CS 21 3+0 38+ 3280 Male
EL CS 36 0+1 38 2610 Female
ELCS 29 0+0 39 3800 Male
ELCS 34 PO+2 40 3180 Female
EL CS 23 1+1 38+3 3640 Female
EL CS 32 1+0 41 4170 Female
EL CS 35 1+0 39+ 3970 Female
EL CS 20 1+0 40+4 3800 Male
EL CS 36 1+0 39 3380 Male
EL CS 35 2+0 38+5 3180 Female
EL CS 29 1+0 39+1 3800 Male
EL CS 22 1+0 39 3940 Male
EL CS 22 1+0 39 3120 Female
SVD 22 0+1 39+4 2950 Male
SVD 28 1+0 41+ 3550 Female
SVD 20 1+2 39 3400 Male
SVD 24 P3+0 39+1 4370 Male
SVD 26 1+0 39+6 3400 Male
SVD 35 0+0 40 3090 Male
SVD 19 0+0 40+3 3940 Male
SVD 26 0+0 38+5 3090 Female
SVD 17 0+0 39+6 4200 Female
SVD 31 1+0 40+1 4760 Male
SVD 22 1+0 41+2 3490 Female
SVD 34 1+0 40+4 3830 Female
SVD 31 1+0 41+1 3580 Male
SVD 35 0+0 40+3 3280 Female
SVD 29 5+0 40+ 3400 Male
SVD 18 (HO 39 3250 Male
SVD 24 2+0 40+2 3060 Female
Pre term-CS 31 P0+0 36+1 3060 Male
Pre term -CS 25 0+0 32+6 1805 Female
Pre term-SVD 27 0+0 35+4 2670 Male
Pre term-SVD 37 2+3 34 2175 Female
Pre term-SVD 19 (HO 36+2 2870 Male
Pre term-SVD 28 1+0 36+4 3230 Male
Pre term-SVD 18 0+0 27+6 1075 Female
Pre term-SVD 22 1+0 33+4 2280 Male
Pre term-SVD 31 2+3 26 870 Female
Pre term-SVD 26 0+0 31+6 1715 Female
Pre term-SVD 18 0+0 25 860 Male
Pre term-SVD 34 0+0 36+4 3110 Male
Pre term -CS 31 0+1 31 1270 Male
Pre term -CS 25 0+0 33 2020 Female
Pre term-SVD 15 0+0 33+6 2610 Male
Appendix3
Proforma for recording maternal and fetal details
Addressograph/Label- MUM
Age
Obstetric History
EDD Date of Delivery
Medical Condition
Complications in Pregnancy
Smoking/Alcohol
Medications/Drugs
Gestation at delivery
Mode of delivery
Placental weight Time arrived in lab
Gravida /Parity
Time of delivery
Indication (If relevant)
Time of PEC Time of Harvest
BABY-
Hospital No.
Birth Weight (Kgs/gms) 
Length(cms)
Head Circumference (cms)
Apgar Scores
Gender
Any Medical condition 
Record of Fetal Distress
Appendix4*
Calibration qPCR
1 2 3 4 5 6 7 8 9 1 0 11 1 2
-
— NOT --- — IN — — U S E — — -
Placenta
3000 -
Placenta
1000 -
Placenta
300 -
Placenta
100 -
Placenta
30 -
Placenta
10 -
Spleen
3000 -
Spleen
1000 -
Spleen
300 -
Spleen
100 - +
Spleen
30 -
Spleen
10 -
Placenta
NTC - NEG NEG
Spleen
NTC -
Placenta
3000 -
Placenta
1000 -
Placenta
300 -
Placenta
100 -
Placenta
30 -
Placenta
10 - >
Spleen
3000 -
Spleen
1000 -
Spleen
300 - >
Spleen
100 - >
Spleen
30 -
Spleen
10 -
• Placenta and spleen samples at different strengths in triplicates.
• NEG- Negative control in triplicate
• NTC- No Template Control in triplicate
v
Appendix5
Plate Plan per PCR
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2
A - — NOT — — IN --- — USE — — -
B - 064 - - 080 - - 118 - - 123 -
C - 069 - - 082 - - 083 - - 086 -
D < - 133 - « - 139 - - 093 - - 125 -
E - 194 - - 224 - - 124 - - 128 -
F < - 137 - - 172 - - NEG - - NTC -
G
Placenta
3000 -
Placenta
1000 -
Placenta
300 -
Placenta
100 -
H
Placenta
30 -
Placenta
10 -
Spleen
1000 -
Spleen
300 -
Plate 1
Plate-2
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2
A - — NOT --- — IN --- — USE — — -
B - 117 - - 149 - - 134 - - 135 -
C - 143 - - 148 - > - 091 - - 196 -
D - 142 - - 197 - > « - 150 - - 173 -
E < - 234 - - 239 - 136 - « - 138 -
F - 175 - - 176 - - NEG - - NTC -
G
Spleen
3000 - +
Spleen
1000 -
Spleen
300 -
Spleen
100 -
H
Spleen
30 -
Spleen
10 -
Placenta
1000 -
Placenta
300 -
•  The numbers on the plate (row s-A -F ) are the sam ple numbers em ployed in 
the study (A ppendix-2) and include sam ples from the 3 experim ental groups. 
Each sam ple is in triplicate.
•  NEG - N egative  control in triplicate
•  NTC - N o  Tem plate Control in triplicate
•  Placenta and spleen  sam ples (row s-G -H ) served both as standards and 
calibrators in triplicate.
Appendix6 
(qPCR Results from Chapter3)
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Comparison of qPCR results for TLRs 1-10 from placenta and spleen along 
with negative control.
Ct is the point at which fluorescence crosses threshold and the values show n are the 
average o f  triplicate.
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TLR5: placenta Ct = 26.33, spleen Ct = 28.10
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TLR6: placenta Ct = 26.70, spleen Ct = 25.63
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TLR7: placenta Ct = 25.87, spleen Ct = 26.80
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TLR8: placenta Ct = 28.53, spleen Ct = 27.90
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TLR9: placenta Ct = 28.37, spleen Ct = 25.17
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TLR10: placenta Ct = 31.13, spleen Ct = 26.23
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Appendix7 
Results from Chapter 4
Comparison o f  cytokine outputs o f  non-laboured versus laboured placental explants in response to 
TLR ligands
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